context/summary-kennethreitz.tsv

1	#Promethease	tab-genotype	0.1.109	2011-03-17 10:05
2	#Column-names
3	Name	Magnitude	PopulationFreq	Description
4	gs1039	5.0		This is the genoset for a mitochondrial DNA haplogroup. H5 is a subclade of H.
5	gs144	4.0		Male.
6	gs191	3.1		impaired NSAID drug metabolism, which is a risk factor for gastrointestinal bleeding when taking any of these medications: aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib. You have one of these *CYP2C8*3 (rs11572080 and rs10509681) *CYP2C9*2 (rs1799853) *CYP2C9*3 (rs1057910)
7	gs127	3.0		This genoset is linked to warfarin metabolism. An individual is considered to be an 'intermediate' metabolizer of warfarin if they carry either a single CYP2C9*2 allele or a single CYP2C9*3 allele, as defined by SNPs rs1799853 and rs1057910, respectively.
8	gs161	3.0		CYP2C9 poor metabolizers may require slightly different dosages for drugs such as tamoxifen, warfarin, fluvastin, and many nonsteroidal anti-inflammatory agents such as aspirin, ibuprofen and naproxen.
9	rs1801282(C;G)	3.0	15.9%	watch out for high fat in diet
10	rs11614913(C;C)	3.0	33.6%	increased risk of various types of cancer This variant increases risk of numerous types of cancer in many studies. It is in a microRNA
11	rs1333049(C;G)	3.0	50.4%	1.5x increased risk for CAD 1.5x higher risk for coronary artery disease
12	rs7754840(C;C)	3.0	9.7%	1.3x increased risk for type-2 diabetes
13	rs1426654(A;A)	2.7	100.0%	probably light-skinned, European ancestry This SNP influences skin pigmentation and indicates indicates light-skinned european ancestry. estimates that the rs1426654(A) allele (light skin pigmentation), spread through the European population around 6,000 - 12,000 years ago. Prior to that, 'European ancestors' were most likely relatively brown-skinned.
14	rs16847548(C;C)	2.5	0.0%	2.6x increased risk for sudden cardiac death in Caucasians
15	rs5361(C;C)	2.5	1.8%	4x increased risk for recurrent venous thromboembolism. rs5361(C;C) homozygous carriers of the Ser128Arg allele are at a 4X higher risk for recurrent venous thromboembolism (VTE); heterozygous carriers are not at increased risk. .
16	rs4680(A;A)	2.5	24.8%	advantage in memory and attention tasks (worrier strategy) Little or no response to modafinil. You are more difficult to hypnotise.
17	rs10490924(G;T)	2.5	38.1%	2.7x risk for age related macular degeneration
18	rs5888(C;T)	2.5	53.6%	3x higher risk for age-related macular degeneration
19	i4000189(T;T)	2.5	None	P40+ Match for Haplogroup I1 (Y-DNA). [haplogroup:I1 (Y-DNA)]
20	rs6265(A;G)	2.4	33.6%	impaired motor skills learning? On a driving-based motor learning task subjects with this genotype showed greater error during short-term learning and poorer retention over 4 days, relative to subjects without the polymorphism. The presence of this BDNF polymorphism is associated with differences in brain motor system function, altered short-term plasticity, and greater error in short-term motor learning. Wired discusses the research as does spittoon. Alzheimer's disease risk for non ApoE4 carriers is affected by the heterozygous form of rs6265
21	rs3825942(C;C)	2.3	68.3%	common but 10x higher glaucoma risk This genotype is found in 2 out of 3 people, but has been repeatedly linked to a much higher risk of glaucoma. However a 2010 paper in a south african population reports reduced risk, casting some doubts.
22	rs1136287(T;T)	2.2	48.7%	3.9x increased risk of wet ARMD age related macular degeneration
23	rs2294008(T;T)	2.1	16.8%	increased risk of gastric and bladder cancer
24	rs279858(G;G)	2.1	24.8%	apparently more prone to alcoholism interacts with the medicine Finasteride
25	rs601338(A;A)	2.1	30.4%	resistance to Norwalk virus infection A study of 115 Swedish adults concluded that this genotype confers genetic immunity to infection by the Norwalk norovirus, a major (and contagious) cause of acute gastroenteritis worldwide.(PMID 12692541) (PMID 16306606)
26	rs2511989(A;G)	2.1	40.7%	0.63x decreased age-related macular degeneration risk
27	rs3775291(A;G)	2.1	47.8%	0.71x decreased risk for dry age related macular degeneration
28	rs646776(A;A)	2.1	54.9%
29	rs6983267(G;T)	2.1	54.9%	1.2x risk of prostate cancer 1.2x risk of prostate cancer
30	rs1815739(C;T)	2.1	58.4%	mix of sprinting & endurance muscles
31	rs10811661(T;T)	2.1	65.5%	1.2x increased risk for type-2 diabetes
32	rs1042522(G;G)	2.1	61.5%	Accelerated lung decline in smokers
33	gs101	2.0		77% of Europeans with this are able to digest lactose and dairy products. People without this are more likely to experience lactose intolerance.
34	gs104	2.0		People with this genoset may carry the haplotype described in gs103 for restless leg syndrome
35	gs108	2.0		This genoset may indicate the haplotype CTCC which has been linked to rheumatoid arthritis by may carry the haplotypes of *rs6311C/T *rs1328674A/G *rs6313C/T *rs6314C/T
36	gs132	2.0		possibly type A blood according to the ABO blood group types. From a molecular point of view, there are 2 A types: AA, and AO, based on whether the individual is carrying two type A alleles or one type A allele plus one type O allele.
37	gs159	2.0		Your CYP1A2 fast metabolizer status means that you are less stimulated by caffeine.
38	gs173	2.0		CYP2D6*10 reduced metabolism
39	gs213	2.0		All available markers match for Haplogroup R (Y-DNA). This haplogroup has subclades under it. The most specific subclade match is the most significant. Haplogroup R (Y-DNA) represents one of two major European Y chromosome haplogroups (the other major haplogroup is Haplogroup I (Y-DNA)). The majority of European Y chromosomes belong to Haplogroup R (Y-DNA). Haplogroup R (Y-DNA) is now defined by eight mutations: * M207 = rs2032658(G) * M306 = rs1558843(A) * P224 = rs17307398(T) * P227 = rs4481791(C) * P232 = rs9786261(A) * P280 = rs891407(G) * P285 = rs17249974(A) In contrast to gs196 all available markers must agree, so a single no-call will prevent this from being recognized. This may be overly strict, and further generalizations for other testing platforms may be warranted. To prevent f...
40	rs12567232(A;A)	2.0	0.0%	Increased risk for Crohn's Disease
41	rs4673(T;T)	2.0	9.7%	3.9x increased risk for cerebral ischemia
42	rs10090154(C;T)	2.0	10.9%	1.4x increased risk for prostate cancer
43	rs10455872(A;G)	2.0	12.3%	increased Coronary Heart disease risk
44	rs13376333(T;T)	2.0	14.2%	~2x higher risk of atrial fibrillation
45	rs3738401(A;A)	2.0	15.2%	rs3738401(A;A) and rs751229(G;G) together indicate homozygosity for the HEP3 haplotype of DISC1.
46	rs1160312(G;G)	2.0	21.2%	reduced risk of baldness reduced risk of baldness
47	rs6495306(G;G)	2.0	21.2%
48	rs17822931(C;T)	2.0	23.2%	wet earwax
49	rs1042725(C;C)	2.0	28.3%	~0.8cm taller
50	rs1393350(A;G)	2.0	29.2%
51	rs3135391(C;T)	2.0	29.2%	HLA-DRB1*1501 carrier; higher multiple sclerosis risk
52	rs4054823(T;T)	2.0	32.1%	1.26x higher risk of aggressive form of prostate cancer The (T;T) genotype does not indicate a higher risk of prostate cancer. It indicates that those with prostate cancer have a 26% higher chance of having the aggressive form which requires more aggressive treatment.
53	rs3821236(A;G)	2.0	32.7%	1.4x higher risk of lupus increased risk of [Systemic lupus erythematosus.
54	rs4654748(C;C)	2.0	33.6%	2.90 ng/mL lower Vitamin B6 blood concentration
55	rs261332(A;G)	2.0	34.8%	associated with higher HDL cholesterol
56	rs9886784(A;C)	2.0	35.4%	3.2x risk for AD
57	rs4420638(A;G)	2.0	36.7%	~3x increased Alzheimer's risk; 1.4x increased heart disease risk ; increased LDL cholesterol
58	rs2987983(C;T)	2.0	39.8%	1.2x increased risk of prostate cancer This genotype is at increased risk of prostate cancer Recommendation: To reduce the risk eat a diet rich in phytoestrogens such as flax seed
59	rs4402960(G;T)	2.0	39.8%	1.2x increased risk for type-2 diabetes
60	rs9923231(C;T)	2.0	40.7%	reduced warfarin dose if treated for VTE
61	rs2981582(C;T)	2.0	41.6%	1.3x higher risk of ER+ breast cancer
62	rs17070145(C;T)	2.0	42.5%	increased memory performance
63	rs1801133(C;T)	2.0	44.2%	multiple, incl 1.17x for gastric cancer, also lung cancer
64	rs3764261(G;T)	2.0	44.2%	associated with higher HDL cholesterol
65	rs237025(C;T)	2.0	45.1%	contributes to both type-1 diabetes and type-2 diabetes This press release provides a helpful summary of . The paper concludes that in rs237025, the MET form increases the odds of type-1 diabetes. This form produces both MET and VAL. suggests the contribution of rs237025 to both type 1 and type 2 diabetes susceptibility.
66	rs17782313(C;T)	2.0	46.0%	adults likely to be 0.22 BMI units higher
67	rs10086908(C;T)	2.0	47.8%	1.7x increased risk for prostate cancer
68	rs4481887(G;G)	2.0	48.7%	57%% of you can smell asparagus metabolites in urine
69	rs1333048(A;C)	2.0	49.6%	1.3x increased coronary artery disease risk
70	rs10757278(A;G)	2.0	50.0%	1.3x risk for MI
71	rs17576(A;G)	2.0	51.3%	higher risk for MI and lung cancer, and, COPD in smokers
72	rs6457617(C;T)	2.0	51.3%	2.3x risk of rheumatoid arthritis
73	rs4149268(G;G)	2.0	52.2%	associated with higher HDL cholesterol
74	rs2383207(A;G)	2.0	52.2%	increased risk for heart disease
75	rs499697(T;T)	2.0	53.1%	straighter hair
76	rs1864163(G;G)	2.0	53.2%	associated with higher HDL cholesterol
77	rs6997709(G;G)	2.0	54.0%	1.5x higher risk for hypertension
78	rs6897932(C;C)	2.0	59.3%	1.5x increased risk for multiple sclerosis
79	rs7442295(A;A)	2.0	60.2%	~4x higher risk for hyperuracemia
80	rs27072(C;C)	2.0	67.9%	2x risk of severe alcohol withdrawal
81	rs7250581(G;G)	2.0	69.0%	1.4x risk 1.4x higher risk for coronary artery disease
82	rs1385699(T;T)	2.0	70.8%	increased risk of baldness slightly higher risk of baldness
83	rs2619522(T;T)	2.0	70.8%	impaired cognitive ability impaired cognitive ability
84	rs17672135(T;T)	2.0	75.0%	1.3x risk
85	i3003626(D;I)	2.0	None
86	rs1065852(C;T)	2.0	None	Carrier of one CYP2D6 decreased or non-functioning variant. Your body may have a reduced ability to process some medicines. You are a carrier for rs1065852(T;T)
87	rs2230199(G;G)	2.0	4.6%	common
88	rs383830(A;A)	2.0	61.9%	1.9x risk 1.9x higher risk for coronary artery disease
89	rs4570625(G;G)	1.9	64.6%	higher scores on anxiety-related personality traits; greater placebo response One study of 25 people shows this genotype was a significant predictor of clinical placebo response, being associated with greater improvement in anxiety symptoms. This SNP has been linked to several psychiatric and/or behavioral phenomena, including: *higher scores on anxiety-related personality traits *obsessive compulsive disorder *panic disorder with a possible gender-dependent effect
90	gs209	1.8		The haplotype A-A-G for SNPs rs3794808, rs140701 and rs4583306 has a 1.7x increased risk for panic disorder. However it seems quite common among the promethease reports.
91	rs3135388(C;T)	1.8	29.2%	3x higher risk of multiple sclerosis
92	rs143383(T;T)	1.8	46.2%	1.3x increased risk for osteoarthritis
93	rs4474514(A;A)	1.8	65.5%	>3x increased testicular cancer risk for men found in 65% of caucasians but linked 3x higher risk of testicular cancer than the (G;G) form.
94	gs140	1.7		Most non-Scandinavian Caucasians and approximately half of African-Americans are slow metabolizers. This variation is important because of its primary role in the deactivation of many chemicals in the body's environment, including those produced by caffeine and cigarettes as well as aromatic amine and hydrazine drugs used medicinally. In general, slow metabolizers have higher rates of certain types of cancer and are more susceptible to side effects from chemicals metabolized by NAT2. According to this source 6 snps determine NAT2 metabolism. The way their genotypes interact is very complex, which makes this one of the largest genosets in SNPedia. The SNPs are: *rs1208 *rs1041983 *rs1799929 *rs1799930 *rs1799931 *rs1801280
95	rs10050860(T;T)	1.7	7.1%	0.71x lower risk for spondylitis
96	rs1042713(A;A)	1.7	12.4%	1.7x increased risk that pediatric inhaler use may make asthma worse
97	rs5400(C;T)	1.7	19.1%	significantly higher sugar consumption?
98	rs8055236(G;G)	1.7	63.7%	common, but 2.2x higher risk for heart disease
99	rs11523871(A;C)	1.6	49.2%	1.6x increased breast cancer risk for women over 60
100	rs3764880(A;A)	1.6	69.2%	1.2 - 1.8x increased tuberculosis risk
101	rs2981745(C;T)	1.6	None	1.6x increased risk for breast cancer in females over 60
102	gs1001	1.5		Haplogroup H probably evolved in West Asia ~30k years ago and arrived to Europe 20-25k years ago, spreading rapidly to the southwest of the continent. About one half of Europeans are of mtDNA haplogroup H. The haplogroup is also common in North Africa and the Middle East. The majority of the European populations have an overall haplogroup H frequency of 40%50%. Frequencies decrease in the southeast of the continent, reaching 20% in the Near East and Caucasus, and <10% in the Persian Gulf, Northern India and Central Asia and up to the Northern reaches of Scandinavia. wikipedia provides more info. This is a mitochondrial haplogroup and a subclade of HV. haplograph provides this image *N **R ***R0 ****HV *****H
103	rs4939883(C;T)	1.5	32.7%	associated with higher HDL cholesterol
104	rs7574865(G;T)	1.5	33.6%	1.3x risk for RA; 1.5x for SLE
105	rs2007153(G;G)	1.5	43.4%	increased risk of schizophrenia in limited study
106	rs6435862(G;T)	1.5	44.6%	1.7x higher risk of aggressive neuroblastoma
107	rs1169300(A;G)	1.5	45.1%	~1.5x increased lung cancer risk
108	rs2464196(C;T)	1.5	45.5%	~1.5x increased lung cancer risk
109	rs11136000(C;T)	1.5	48.7%	0.84x decreased risk for Alzheimer's disease
110	rs872071(A;G)	1.5	48.7%	~1.5x increased risk for chronic lymphocytic leukemia
111	rs464049(C;T)	1.5	50.4%	increased risk of schizophrenia in limited study
112	rs2241880(C;T)	1.5	56.2%	1.4x increased risk for Crohn's disease in Caucasians
113	rs4331145(A;G)	1.5	56.9%	decreased risk of schizophrenia in limited study
114	rs4320932(A;A)	1.5	61.1%	decreased risk of schizophrenia in limited study
115	rs4149274(C;C)	1.5	62.1%	associated with higher HDL cholesterol
116	rs7341475(G;G)	1.5	74.3%	1.58x increased schizophrenia risk for women
117	rs1135840(C;G)	1.5	None	Carrier of at least one CYP2D6 variants (non-CYP2D6*1)
118	rs5186(A;C)	1.5	None	~1.4x increased risk of hypertension
119	rs1447295(A;C)	1.4	12.4%	1.4x increased risk of prostate cancer
120	rs1126497(T;T)	1.4	23.0%	1.4x increased risk for breast cancer
121	rs2280714(A;A)	1.4	35.4%	1.4x increased risk of SLE
122	rs2046210(C;T)	1.4	46.9%	1.4x increased breast cancer risk
123	rs4959039(A;G)	1.4	49.6%	1.4x higher risk for multiple sclerosis
124	rs6495446(C;C)	1.4	61.6%	2.5x increased risk for chronic kidney disease in a small unreplicated study
125	rs3131296(G;G)	1.4	83.0%	1.4x increased risk for schizophrenia
126	rs1800454(A;G)	1.3	23.9%	carrier Since this comes from omim, its supposed to be a rare disorder, but HapMap shows that variation is common
127	rs1434536(A;G)	1.3	56.6%	1.29x increased breast cancer risk
128	rs10947262(C;C)	1.3	88.5%	1.3x increased risk for osteoarthritis
129	rs748404(T;T)	1.25	57.7%	slightly increased risk (1.25) for lung cancer
130	gs184	1.2		normal tasting ability for bitterness
131	rs10865331(A;G)	1.2	45.1%	1.2x higher risk for ankylosing spondylitis
132	rs11246226(A;C)	1.2	55.8%	decreased risk of schizophrenia in limited study
133	rs2223841(A;A)	1.2	69.2%	more likely to go bald before age 40 more likely to go bald before age 40
134	rs6625163(A;A)	1.2	72.6%	increased risk of baldness more likely to go bald
135	rs6036025(G;G)	1.2	84.1%	more likely to go bald more likely to go bald
136	gs218	1.1		You appear to have zero copies of the CNV discussed at . This appears to be somewhat rare. See also gs217
137	rs997669(A;A)	1.1	38.9%	1.18x higher risk for breast cancer
138	rs889312(A;C)	1.1	44.6%	Very slightly higher risk for breast cancer
139	rs363050(A;G)	1.1	46.0%
140	rs4496877(G;T)	1.1	47.8%	For type-1 diabetics, 1.3x increased nephropathy risk
141	rs13387042(A;G)	1.1	48.7%	1.12x increased risk for breast cancer
142	rs1344706(G;T)	1.1	52.3%	1.1x increased risk for schizophrenia
143	rs713598(C;C)	1.1	18.8%	can taste bitter
144	gs150	1.0		Most likely CYP2C19 normal, i.e. CYP2C19*1, and therefore of the 'rapid metabolizer' phenotype. This is based on none of the 11 CYP2C19 variants on the 23andMe v2 chip (out of 19 reported in SNPedia; most are quite rare) being observed.
145	gs154	1.0		You appear to be a CYP3A5 expressor. This is normal. However it is still possible you carry variations which were not tested by your platform.
146	gs182	1.0		CYP2D6*39 normal metabolism
147	rs10427027(C;C)	None	0.0%
148	rs12151144(C;C)	None	0.0%
149	rs12615966(T;T)	None	0.0%
150	rs12911738(A;A)	None	0.0%
151	rs17077540(G;G)	None	0.0%
152	rs2277912(C;C)	None	0.0%
153	rs2854747(T;T)	None	0.0%
154	rs3917657(T;T)	None	0.0%
155	rs4533251(T;T)	None	0.0%
156	rs4984(T;T)	None	0.0%
157	rs705381(C;C)	None	0.0%	normal
158	rs8040502(A;A)	None	0.0%
159	rs926103(G;G)	None	0.0%
160	rs12265684(C;G)	None	0.0%
161	rs2070744(C;T)	None	0.0%	None
162	rs2852464(C;G)	None	0.0%
163	rs557881(C;T)	None	0.0%
164	rs7568369(G;T)	None	0.0%	0.90x reduced risk of obesity
165	rs2048874(T;T)	None	0.9%
166	rs2228375(G;G)	None	0.9%
167	rs2358944(G;G)	None	0.9%
168	rs4626664(A;A)	None	0.9%	>1.44x increased risk for restless legs syndrome
169	rs4762(T;T)	None	0.9%	>1.9x risk for pre-eclampsia
170	rs533123(C;C)	None	0.9%
171	rs6683071(A;A)	None	0.9%
172	rs743507(G;G)	None	0.9%
173	rs1058587(C;G)	None	1.5%
174	rs3735653(A;G)	None	1.5%
175	rs3889728(A;A)	None	1.7%	increased risk for preeclampsia
176	rs12440962(T;T)	None	1.8%
177	rs12526196(C;C)	None	1.8%
178	rs2232387(A;A)	None	1.8%
179	rs2257205(A;A)	None	1.8%
180	rs2304973(T;T)	None	1.8%
181	rs2306374(C;C)	None	1.8%
182	rs2412541(G;G)	None	1.8%
183	rs4660646(G;G)	None	1.8%
184	rs5934953(C;C)	None	1.8%
185	rs7474896(T;T)	None	1.8%
186	rs279552(A;G)	None	1.8%
187	rs11240594(A;A)	None	2.7%
188	rs11574143(A;A)	None	2.7%
189	rs12199222(T;T)	None	2.7%
190	rs12344615(G;G)	None	2.7%
191	rs1574091(C;C)	None	2.7%
192	rs1801265(C;C)	None	2.7%
193	rs4670766(C;C)	None	2.7%
194	rs6788148(A;A)	None	2.7%
195	rs7017300(C;C)	None	2.7%	1.7x increased risk for prostate cancer
196	rs4458717(C;C)	None	3.1%
197	rs6903874(C;C)	None	3.1%
198	rs10502094(A;G)	None	3.1%
199	rs10151259(T;T)	None	3.3%
200	rs2011077(A;A)	None	3.5%	normal
201	rs2880058(G;G)	None	3.5%
202	rs3178250(C;C)	None	3.5%
203	rs4726075(G;G)	None	3.5%
204	rs736707(C;C)	None	3.5%
205	rs7754561(G;G)	None	3.5%
206	rs929230(A;A)	None	3.5%
207	rs1379659(G;G)	None	3.6%
208	rs1650697(T;T)	None	3.6%
209	rs17465637(A;A)	None	3.6%
210	rs5050(G;G)	None	3.6%
211	rs10947803(A;A)	None	4.4%
212	rs1364705(C;C)	None	4.4%
213	rs1374486(T;T)	None	4.4%
214	rs1861973(T;T)	None	4.4%
215	rs1951276(A;A)	None	4.4%
216	rs2690381(A;A)	None	4.4%
217	rs877783(C;C)	None	4.4%
218	rs3772534(A;G)	None	4.4%
219	rs730532(C;C)	None	4.6%
220	rs2975766(A;G)	None	4.6%
221	rs3819102(C;T)	None	4.6%
222	rs10489849(T;T)	None	5.3%
223	rs10807344(T;T)	None	5.3%
224	rs1413191(T;T)	None	5.3%
225	rs1775456(G;G)	None	5.3%
226	rs317689(G;G)	None	5.3%
227	rs3816873(C;C)	None	5.3%	reduced risk of type-2 diabetes
228	rs4311394(G;G)	None	5.3%
229	rs499818(A;A)	None	5.3%
230	rs758502(T;T)	None	5.3%
231	rs8192917(G;G)	None	5.3%
232	rs947211(A;A)	None	5.3%
233	rs2122554(A;C)	None	5.3%
234	rs2287987(C;C)	None	5.4%	0.71x lower risk for spondylitis
235	rs7900744(G;G)	None	5.4%
236	rs9315632(T;T)	None	5.4%
237	rs10206899(C;C)	None	6.2%
238	rs12457996(C;C)	None	6.2%
239	rs1322512(G;G)	None	6.2%
240	rs13538(C;C)	None	6.2%
241	rs1550976(T;T)	None	6.2%
242	rs17664267(T;T)	None	6.2%
243	rs1898830(G;G)	None	6.2%
244	rs1983891(T;T)	None	6.2%
245	rs2061174(C;C)	None	6.2%
246	rs2243191(T;T)	None	6.2%
247	rs225717(C;C)	None	6.2%
248	rs2266690(C;C)	None	6.2%
249	rs2808635(G;G)	None	6.2%
250	rs437943(G;G)	None	6.2%
251	rs6971091(A;A)	None	6.2%	>2x increased risk for familial obesity
252	rs7503034(T;T)	None	6.2%
253	rs7538490(T;T)	None	6.2%
254	rs7900873(A;A)	None	6.2%
255	rs8192558(G;G)	None	6.2%
256	rs9543325(C;C)	None	6.2%
257	rs1328674(A;G)	None	6.2%	higher risk for RA
258	rs16910061(A;G)	None	6.2%
259	rs17036101(A;G)	None	6.2%
260	rs1799944(A;G)	None	6.2%
261	rs3804505(C;T)	None	6.2%	?
262	rs505151(A;G)	None	6.2%
263	rs766173(G;T)	None	6.2%
264	rs11986220(A;T)	None	6.7%
265	rs12941878(A;A)	None	7.0%
266	rs10258719(A;A)	None	7.1%
267	rs10945919(G;G)	None	7.1%
268	rs1234317(T;T)	None	7.1%
269	rs12679254(T;T)	None	7.1%
270	rs13278732(T;T)	None	7.1%
271	rs1458038(A;A)	None	7.1%
272	rs1536482(A;A)	None	7.1%
273	rs154001(C;C)	None	7.1%
274	rs1571801(A;A)	None	7.1%	>1.36x risk for prostate cancer
275	rs17482078(T;T)	None	7.1%	normal risk
276	rs1982151(A;A)	None	7.1%
277	rs2240920(A;A)	None	7.1%
278	rs25651(A;A)	None	7.1%
279	rs2819770(A;A)	None	7.1%
280	rs2991216(C;C)	None	7.1%
281	rs3939286(A;A)	None	7.1%
282	rs4730273(A;A)	None	7.1%
283	rs7221109(T;T)	None	7.1%
284	rs4131805(G;G)	None	7.7%
285	rs17665021(G;T)	None	7.7%
286	rs6439371(G;G)	None	7.9%
287	rs10096097(G;G)	None	8.0%
288	rs10514713(A;A)	None	8.0%
289	rs10984447(G;G)	None	8.0%	common
290	rs1801376(G;G)	None	8.0%
291	rs1805017(A;A)	None	8.0%
292	rs1935949(T;T)	None	8.0%
293	rs211105(G;G)	None	8.0%
294	rs2270450(T;T)	None	8.0%
295	rs2540477(C;C)	None	8.0%
296	rs2808630(C;C)	None	8.0%
297	rs31198(C;C)	None	8.0%
298	rs343064(T;T)	None	8.0%
299	rs3743266(G;G)	None	8.0%
300	rs729302(C;C)	None	8.0%	0.9x decreased rheumatoid arthritis risk
301	rs757411(C;C)	None	8.0%
302	rs9584805(G;G)	None	8.0%
303	rs999986(T;T)	None	8.0%
304	rs10194115(G;T)	None	8.0%
305	rs1055061(A;G)	None	8.0%
306	rs12418204(A;G)	None	8.0%
307	rs16858811(G;T)	None	8.0%
308	rs573542(A;G)	None	8.0%
309	rs965972(C;T)	None	8.0%
310	rs2368392(T;T)	None	8.1%
311	rs9554711(G;G)	None	8.2%
312	rs1004819(T;T)	None	8.8%	common
313	rs10888501(A;A)	None	8.8%
314	rs11084753(A;A)	None	8.8%
315	rs11465817(A;A)	None	8.8%
316	rs12324805(C;C)	None	8.8%
317	rs13831(T;T)	None	8.8%
318	rs2652106(T;T)	None	8.8%
319	rs2660845(G;G)	None	8.8%
320	rs3772130(C;C)	None	8.8%
321	rs4446959(C;C)	None	8.8%
322	rs4771450(G;G)	None	8.8%
323	rs4911414(T;T)	None	8.8%	2-4x higher risk of sun sensitivity if part of risk haplotype
324	rs6687840(T;T)	None	8.8%
325	rs10824310(C;T)	None	8.8%
326	rs28757184(C;T)	None	8.8%
327	rs9627183(A;G)	None	8.8%
328	rs10272438(G;G)	None	8.9%
329	rs1042779(G;G)	None	8.9%
330	rs10781380(C;C)	None	8.9%
331	rs2240335(T;T)	None	8.9%
332	rs7089424(G;G)	None	8.9%
333	rs512577(A;A)	None	9.0%
334	rs6059244(A;A)	None	9.0%
335	rs6736997(A;A)	None	9.0%
336	rs2301888(T;T)	None	9.5%
337	rs1044291(T;T)	None	9.7%
338	rs10821936(C;C)	None	9.7%
339	rs10889676(A;A)	None	9.7%
340	rs10889677(A;A)	None	9.7%	1.5x risk for certain autoimmune diseases
341	rs10946398(C;C)	None	9.7%
342	rs11805303(T;T)	None	9.7%	1.8x risk
343	rs12495941(T;T)	None	9.7%
344	rs2020862(T;T)	None	9.7%
345	rs2344484(C;C)	None	9.7%
346	rs3733242(A;A)	None	9.7%
347	rs3761418(G;G)	None	9.7%	normal risk
348	rs4133289(A;A)	None	9.7%
349	rs4712523(G;G)	None	9.7%
350	rs5762764(G;G)	None	9.7%
351	rs7679673(A;A)	None	9.7%
352	rs7992226(G;G)	None	9.7%
353	rs8079702(G;G)	None	9.7%
354	rs9990174(T;T)	None	9.7%
355	rs12731981(A;G)	None	9.7%
356	rs2229864(C;C)	None	9.8%
357	rs4131099(T;T)	None	9.8%
358	rs7539625(A;A)	None	9.8%
359	rs1918172(C;G)	None	9.8%
360	rs10493256(A;A)	None	9.9%
361	rs12554086(A;A)	None	9.9%
362	rs2180566(C;C)	None	9.9%
363	rs10109700(A;G)	None	10.0%
364	rs11154022(A;A)	None	10.1%
365	rs10494366(G;G)	None	10.6%	Long QT interval
366	rs10774021(C;C)	None	10.6%
367	rs13330107(A;A)	None	10.6%
368	rs1415259(G;G)	None	10.6%
369	rs1889018(C;C)	None	10.6%	normal
370	rs2201841(C;C)	None	10.6%	1.5x risk for Crohn's disease
371	rs3194051(G;G)	None	10.6%	normal
372	rs3936503(A;A)	None	10.6%
373	rs7187167(T;T)	None	10.6%
374	rs9271100(T;T)	None	10.6%
375	rs987107(T;T)	None	10.6%
376	rs9902941(C;C)	None	10.6%
377	rs1528133(A;C)	None	10.6%	higher body mass index
378	rs1705236(A;T)	None	10.6%
379	rs2015747(G;T)	None	10.6%
380	rs7183877(A;C)	None	10.6%	usually brown eye color
381	rs2251219(G;G)	None	10.7%
382	rs2542051(C;C)	None	10.7%
383	rs3018362(A;A)	None	10.7%
384	rs3813928(A;A)	None	10.7%
385	rs7178347(T;T)	None	10.7%
386	rs2812378(C;C)	None	10.8%
387	rs6092477(A;A)	None	10.8%
388	rs863221(G;G)	None	10.8%
389	rs12507099(C;G)	None	10.8%
390	rs6808874(A;T)	None	10.8%
391	rs12479919(T;T)	None	10.9%
392	rs3112831(G;G)	None	10.9%
393	rs4751674(T;T)	None	10.9%
394	rs7832031(A;G)	None	10.9%
395	rs9925481(C;T)	None	10.9%
396	rs1599903(C;C)	None	11.1%
397	rs609438(G;G)	None	11.1%
398	rs16860281(C;T)	None	11.1%
399	rs2240339(A;A)	None	11.3%
400	rs10506328(A;A)	None	11.5%
401	rs12649507(A;A)	None	11.5%
402	rs13160562(A;A)	None	11.5%
403	rs149428(A;A)	None	11.5%
404	rs165774(A;A)	None	11.5%
405	rs1824024(G;G)	None	11.5%
406	rs1889899(G;G)	None	11.5%
407	rs2039461(A;A)	None	11.5%
408	rs2193225(A;A)	None	11.5%
409	rs4627609(C;C)	None	11.5%
410	rs6563943(A;A)	None	11.5%
411	rs805708(G;G)	None	11.5%
412	rs863931(A;A)	None	11.5%
413	rs2279434(C;T)	None	11.5%
414	rs4988514(C;T)	None	11.5%
415	rs9658625(A;G)	None	11.5%
416	rs2304256(A;A)	None	11.6%	normal
417	rs6505162(C;C)	None	11.6%	normal
418	rs7069923(T;T)	None	11.6%
419	rs224534(A;A)	None	11.7%
420	rs3794808(A;A)	None	11.7%
421	rs4583306(G;G)	None	11.7%
422	rs1521791(T;T)	None	12.0%
423	rs12722(C;C)	None	12.3%
424	rs1340513(C;C)	None	12.3%
425	rs2536512(A;A)	None	12.3%
426	rs8069834(A;A)	None	12.3%
427	rs17216525(C;T)	None	12.3%
428	rs9891361(A;G)	None	12.3%
429	rs1022442(A;A)	None	12.4%
430	rs1043424(C;C)	None	12.4%
431	rs140701(A;A)	None	12.4%	increased risk for anxiety disorders
432	rs1467465(T;T)	None	12.4%	normal
433	rs1524058(T;T)	None	12.4%
434	rs2542052(A;A)	None	12.4%
435	rs301430(C;C)	None	12.4%
436	rs3755351(A;A)	None	12.4%	average
437	rs3762271(A;A)	None	12.4%
438	rs3842936(A;A)	None	12.4%
439	rs4251961(C;C)	None	12.4%
440	rs4730276(A;A)	None	12.4%
441	rs6682654(G;G)	None	12.4%	1.8x increased risk for rheumatoid arthritis
442	rs6686842(T;T)	None	12.4%
443	rs840088(T;T)	None	12.4%
444	rs9803659(C;C)	None	12.4%
445	rs10488031(A;G)	None	12.4%
446	rs11964281(C;T)	None	12.4%
447	rs246246(G;T)	None	12.4%
448	rs3750861(C;T)	None	12.4%
449	rs4242382(A;G)	None	12.4%	1.7x increased risk for prostate cancer
450	rs4242384(A;C)	None	12.4%
451	rs694066(A;G)	None	12.4%
452	rs7019241(C;T)	None	12.4%	reduced risk for AD?
453	rs11168048(C;C)	None	12.5%
454	rs3766379(T;T)	None	12.5%	1.9x increased risk for rheumatoid arthritis
455	rs680379(A;A)	None	12.5%
456	rs29941(T;T)	None	12.6%
457	rs362988(A;A)	None	12.6%
458	rs4788084(A;A)	None	12.6%
459	rs11155795(G;G)	None	12.7%
460	rs1042173(G;G)	None	13.3%	normal
461	rs10514995(G;G)	None	13.3%
462	rs1056484(A;A)	None	13.3%
463	rs10794595(T;T)	None	13.3%
464	rs10901850(T;T)	None	13.3%
465	rs12035082(C;C)	None	13.3%
466	rs12037606(A;A)	None	13.3%	1.5x risk of Crohn's disease
467	rs151181(G;G)	None	13.3%
468	rs1566439(G;G)	None	13.3%
469	rs16901937(G;G)	None	13.3%
470	rs1799990(G;G)	None	13.3%	normal confers susceptibility for the development of sporadic CJD
471	rs1896731(C;C)	None	13.3%
472	rs2943634(A;A)	None	13.3%
473	rs2957128(A;A)	None	13.3%
474	rs3813034(C;C)	None	13.3%
475	rs3995090(C;C)	None	13.3%
476	rs4415084(T;T)	None	13.3%
477	rs4799915(C;C)	None	13.3%
478	rs4864548(A;A)	None	13.3%	normal
479	rs6451770(G;G)	None	13.3%
480	rs6477872(C;C)	None	13.3%
481	rs6552828(A;A)	None	13.3%
482	rs6774494(A;A)	None	13.3%
483	rs776488(C;C)	None	13.3%
484	rs887304(A;A)	None	13.3%
485	rs952094(A;A)	None	13.3%
486	rs10512049(C;T)	None	13.3%
487	rs10868366(G;T)	None	13.3%	reduced risk for AD?
488	rs11134178(C;T)	None	13.3%
489	rs11191548(C;T)	None	13.3%
490	rs11984145(C;T)	None	13.3%
491	rs12413409(A;G)	None	13.3%
492	rs16928809(A;G)	None	13.3%
493	rs1800407(A;G)	None	13.3%	green/hazel/brown/black eyes more likely
494	rs696217(G;T)	None	13.3%
495	rs716595(A;G)	None	13.3%
496	rs10433903(C;C)	None	13.4%
497	rs1052030(C;C)	None	13.4%
498	rs138110(G;G)	None	13.4%
499	rs1731017(T;T)	None	13.4%
500	rs1999805(C;C)	None	13.4%
501	rs2571445(T;T)	None	13.4%
502	rs7672826(A;A)	None	13.4%
503	rs201571(C;C)	None	13.5%
504	rs2493137(C;C)	None	13.5%
505	rs2948694(A;G)	None	13.5%	increased risk for heavy alcohol consumption
506	rs11568817(G;G)	None	13.8%
507	rs1041163(C;T)	None	13.8%
508	rs11105378(C;T)	None	13.8%
509	rs17249754(A;G)	None	13.8%
510	rs4792847(A;A)	None	14.1%
511	rs10521232(C;C)	None	14.2%
512	rs10999409(T;T)	None	14.2%
513	rs11761683(C;C)	None	14.2%
514	rs1477196(A;A)	None	14.2%
515	rs1800759(A;A)	None	14.2%	increased risk for alcohol or drug dependence; increased agreeableness (?)
516	rs2053506(G;G)	None	14.2%
517	rs2194980(A;A)	None	14.2%
518	rs225190(G;G)	None	14.2%
519	rs2279345(T;T)	None	14.2%
520	rs3780792(G;G)	None	14.2%
521	rs7214479(T;T)	None	14.2%
522	rs7495052(C;C)	None	14.2%
523	rs7578326(G;G)	None	14.2%
524	rs7612209(G;G)	None	14.2%
525	rs7652589(A;A)	None	14.2%
526	rs8215(T;T)	None	14.2%
527	rs9836484(A;A)	None	14.2%
528	rs10937275(A;G)	None	14.2%
529	rs17115100(G;T)	None	14.2%
530	rs1736557(A;G)	None	14.2%
531	rs17385675(C;T)	None	14.2%
532	rs1805012(C;T)	None	14.2%
533	rs7297610(C;T)	None	14.2%
534	rs7837688(G;T)	None	14.2%	1.7x increased risk for prostate cancer
535	rs1327474(G;G)	None	14.3%
536	rs2152750(A;A)	None	14.3%
537	rs2297595(C;T)	None	14.3%
538	rs6665776(A;C)	None	14.4%
539	rs237897(A;A)	None	14.5%
540	rs4504469(T;T)	None	14.5%	> 1.5x risk
541	rs2300039(C;C)	None	14.8%
542	rs9935563(T;T)	None	14.8%
543	rs10510181(A;A)	None	15.0%
544	rs11070795(G;G)	None	15.0%
545	rs1451375(A;A)	None	15.0%
546	rs1558744(A;A)	None	15.0%
547	rs1880753(G;G)	None	15.0%
548	rs2157249(C;C)	None	15.0%
549	rs2234693(C;C)	None	15.0%
550	rs2329340(T;T)	None	15.0%
551	rs2619112(A;A)	None	15.0%
552	rs2943641(T;T)	None	15.0%
553	rs314280(T;T)	None	15.0%
554	rs356220(T;T)	None	15.0%
555	rs3808607(G;G)	None	15.0%
556	rs3922812(T;T)	None	15.0%
557	rs4276913(G;G)	None	15.0%
558	rs4742(C;C)	None	15.0%
559	rs498793(A;A)	None	15.0%
560	rs6687360(T;T)	None	15.0%
561	rs7134599(A;A)	None	15.0%
562	rs7844723(C;C)	None	15.0%
563	rs8049439(C;C)	None	15.0%
564	rs8099594(G;G)	None	15.0%
565	rs921451(C;C)	None	15.0%
566	rs9374080(C;C)	None	15.0%
567	rs9479055(C;C)	None	15.0%
568	rs1004467(C;T)	None	15.0%
569	rs11643520(C;T)	None	15.0%
570	rs1805011(A;C)	None	15.0%
571	rs2203512(A;G)	None	15.0%
572	rs4318720(A;G)	None	15.0%
573	rs4968363(C;T)	None	15.0%
574	rs6463089(A;G)	None	15.0%
575	rs789852(C;T)	None	15.0%
576	rs8192772(C;T)	None	15.0%
577	rs977214(A;G)	None	15.0%
578	rs10195252(C;C)	None	15.2%
579	rs1061305(G;G)	None	15.2%
580	rs12044355(C;C)	None	15.2%
581	rs4243849(G;G)	None	15.2%
582	rs7678436(A;G)	None	15.2%
583	rs701848(C;C)	None	15.3%
584	rs763110(T;T)	None	15.3%	~0.80x reduced cancer risk
585	rs12344488(A;G)	None	15.3%
586	rs12460876(C;C)	None	15.4%
587	rs29684(T;T)	None	15.4%
588	rs7885458(C;C)	None	15.4%
589	rs8047395(G;G)	None	15.4%
590	rs4519796(G;G)	None	15.5%
591	rs16851009(C;T)	None	15.5%
592	rs1035050(C;C)	None	15.9%
593	rs1050993(A;A)	None	15.9%
594	rs1105434(A;A)	None	15.9%
595	rs17309827(G;G)	None	15.9%
596	rs17563(T;T)	None	15.9%
597	rs1770449(G;G)	None	15.9%
598	rs1823023(A;A)	None	15.9%
599	rs182784(G;G)	None	15.9%
600	rs1953600(T;T)	None	15.9%
601	rs2060793(A;A)	None	15.9%
602	rs2277680(A;A)	None	15.9%
603	rs2504063(A;A)	None	15.9%
604	rs2822432(T;T)	None	15.9%
605	rs2853523(A;A)	None	15.9%
606	rs3760738(A;A)	None	15.9%
607	rs6070035(G;G)	None	15.9%
608	rs660652(A;A)	None	15.9%
609	rs6902771(T;T)	None	15.9%
610	rs762642(G;G)	None	15.9%
611	rs8047014(C;C)	None	15.9%
612	rs9322817(C;C)	None	15.9%
613	rs9351265(C;C)	None	15.9%
614	rs10033464(G;T)	None	15.9%	1.4x increased risk of atrial fibrillation and ischemic stroke
615	rs1568282(A;G)	None	15.9%
616	rs2197423(C;T)	None	15.9%
617	rs2637496(C;T)	None	15.9%
618	rs3025035(C;T)	None	15.9%
619	rs3795391(C;T)	None	15.9%
620	rs4684847(C;T)	None	15.9%
621	rs544368(A;G)	None	15.9%
622	rs6556756(G;T)	None	15.9%
623	rs6802898(C;T)	None	15.9%
624	rs7715300(A;G)	None	15.9%
625	rs7945931(A;G)	None	15.9%
626	rs1946518(T;T)	None	16.1%
627	rs287354(T;T)	None	16.1%
628	rs38845(A;A)	None	16.1%
629	rs7217186(C;C)	None	16.1%
630	rs13117172(C;T)	None	16.1%
631	rs1805005(G;T)	None	16.1%
632	rs1899951(A;G)	None	16.1%
633	rs7955866(A;G)	None	16.1%
634	rs10431058(T;T)	None	16.4%
635	rs588765(T;T)	None	16.4%
636	rs7667298(T;T)	None	16.4%
637	rs7901656(C;C)	None	16.4%
638	rs2852894(C;T)	None	16.7%
639	rs1004982(G;G)	None	16.8%
640	rs10276036(C;C)	None	16.8%
641	rs1049550(T;T)	None	16.8%	0.62x reduced risk for sarcoidosis
642	rs10504543(A;A)	None	16.8%
643	rs10770705(A;A)	None	16.8%
644	rs11239177(C;C)	None	16.8%
645	rs1128503(T;T)	None	16.8%	likely to require more methadone during heroin withdrawal
646	rs1208(G;G)	None	16.8%
647	rs12896399(G;G)	None	16.8%
648	rs16948048(G;G)	None	16.8%
649	rs1946519(A;A)	None	16.8%
650	rs2212596(C;C)	None	16.8%
651	rs2976392(A;A)	None	16.8%
652	rs3212183(C;C)	None	16.8%
653	rs3820928(G;G)	None	16.8%
654	rs4333130(C;C)	None	16.8%
655	rs4692256(C;C)	None	16.8%
656	rs4794665(G;G)	None	16.8%
657	rs6457327(A;A)	None	16.8%
658	rs6860(A;A)	None	16.8%
659	rs7582658(A;A)	None	16.8%
660	rs876537(T;T)	None	16.8%
661	rs9382658(A;A)	None	16.8%
662	rs9388489(G;G)	None	16.8%
663	rs10411210(C;T)	None	16.8%
664	rs10481151(C;T)	None	16.8%
665	rs12110693(A;G)	None	16.8%
666	rs12446956(C;T)	None	16.8%
667	rs1487276(A;G)	None	16.8%
668	rs17388587(A;G)	None	16.8%
669	rs17632542(C;T)	None	16.8%
670	rs2242048(C;T)	None	16.8%
671	rs2276707(C;T)	None	16.8%
672	rs2304130(A;G)	None	16.8%
673	rs254487(G;T)	None	16.8%
674	rs3814057(A;C)	None	16.8%
675	rs6817306(C;T)	None	16.8%
676	rs783396(A;C)	None	16.8%
677	rs17582416(G;G)	None	16.9%
678	rs1948632(G;G)	None	16.9%
679	rs2710057(G;G)	None	16.9%
680	rs356219(G;G)	None	16.9%
681	rs4509385(T;T)	None	16.9%
682	rs3901517(C;G)	None	16.9%
683	rs4947019(C;G)	None	16.9%
684	rs6578993(C;T)	None	16.9%
685	rs1042580(G;G)	None	17.0%
686	rs1799929(T;T)	None	17.0%
687	rs3131018(T;T)	None	17.0%
688	rs951439(T;T)	None	17.0%
689	rs1223271(A;G)	None	17.0%
690	rs1881797(C;T)	None	17.0%
691	rs1003719(A;A)	None	17.1%
692	rs1328369(G;G)	None	17.1%
693	rs2293275(A;A)	None	17.1%
694	rs16996148(G;T)	None	17.1%
695	rs17279437(A;G)	None	17.1%
696	rs7085433(A;G)	None	17.1%
697	rs4339211(T;T)	None	17.2%
698	rs6814664(T;T)	None	17.2%
699	rs6834893(T;T)	None	17.2%
700	rs12046117(C;T)	None	17.2%
701	rs1460163(A;G)	None	17.3%
702	rs1004984(T;T)	None	17.4%
703	rs10018204(T;T)	None	17.5%
704	rs4845617(A;A)	None	17.5%
705	rs13107325(C;T)	None	17.6%
706	rs10039254(G;G)	None	17.7%
707	rs1038304(G;G)	None	17.7%
708	rs1048101(C;C)	None	17.7%
709	rs10506525(A;A)	None	17.7%
710	rs11082304(G;G)	None	17.7%
711	rs11685878(T;T)	None	17.7%
712	rs11974297(G;G)	None	17.7%
713	rs12256138(T;T)	None	17.7%
714	rs138060(A;A)	None	17.7%
715	rs1490388(T;T)	None	17.7%
716	rs1512268(A;A)	None	17.7%
717	rs1530293(A;A)	None	17.7%
718	rs1957860(T;T)	None	17.7%
719	rs1997794(C;C)	None	17.7%
720	rs2011616(A;A)	None	17.7%
721	rs2088885(C;C)	None	17.7%
722	rs3829241(A;A)	None	17.7%
723	rs3895874(G;G)	None	17.7%
724	rs447372(A;A)	None	17.7%
725	rs6027755(A;A)	None	17.7%
726	rs616256(A;A)	None	17.7%
727	rs6214(A;A)	None	17.7%
728	rs6585827(A;A)	None	17.7%
729	rs708486(C;C)	None	17.7%
730	rs7843479(A;A)	None	17.7%
731	rs8041675(T;T)	None	17.7%
732	rs9834970(T;T)	None	17.7%
733	rs9870680(T;T)	None	17.7%
734	rs1007023(G;T)	None	17.7%
735	rs10401969(C;T)	None	17.7%
736	rs16936455(A;G)	None	17.7%
737	rs17571(C;T)	None	17.7%
738	rs2409191(A;G)	None	17.7%
739	rs2681472(C;T)	None	17.7%
740	rs2877832(C;T)	None	17.7%
741	rs12744386(T;T)	None	17.9%
742	rs2277025(C;C)	None	17.9%
743	rs4775899(T;T)	None	17.9%
744	rs4819756(A;A)	None	17.9%
745	rs2986971(G;G)	None	18.0%
746	rs11683487(T;T)	None	18.3%
747	rs10939038(T;T)	None	18.5%
748	rs1143672(A;A)	None	18.5%
749	rs17185835(G;G)	None	18.5%
750	rs17185870(A;A)	None	18.5%
751	rs1801280(C;C)	None	18.5%
752	rs2008720(C;C)	None	18.5%
753	rs2842030(G;G)	None	18.5%
754	rs6449155(G;G)	None	18.5%
755	rs6449159(A;A)	None	18.5%
756	rs6449201(T;T)	None	18.5%
757	rs6823361(G;G)	None	18.5%
758	rs6844316(G;G)	None	18.5%
759	rs7376948(A;A)	None	18.5%
760	rs7378305(T;T)	None	18.5%
761	rs7676733(A;A)	None	18.5%
762	rs7677710(G;G)	None	18.5%
763	rs972283(A;A)	None	18.5%
764	rs11663206(C;T)	None	18.5%
765	rs1386494(A;G)	None	18.5%
766	rs1549759(A;G)	None	18.5%
767	rs1655285(C;G)	None	18.5%
768	rs4805834(C;T)	None	18.5%
769	rs7272891(C;G)	None	18.5%
770	rs7657958(A;G)	None	18.5%
771	rs1001761(T;T)	None	18.6%
772	rs10994982(A;A)	None	18.6%
773	rs1128349(G;G)	None	18.6%
774	rs12503643(T;T)	None	18.6%
775	rs1424233(G;G)	None	18.6%
776	rs1569198(G;G)	None	18.6%
777	rs1870063(T;T)	None	18.6%
778	rs2235046(A;A)	None	18.6%
779	rs2236648(T;T)	None	18.6%
780	rs2291726(C;C)	None	18.6%
781	rs2395730(C;C)	None	18.6%
782	rs2548861(T;T)	None	18.6%
783	rs2847149(A;A)	None	18.6%
784	rs2959799(C;C)	None	18.6%
785	rs3177751(C;C)	None	18.6%
786	rs3213427(C;C)	None	18.6%
787	rs6545977(A;A)	None	18.6%
788	rs7076247(T;T)	None	18.6%
789	rs8034284(T;T)	None	18.6%
790	rs865686(G;G)	None	18.6%
791	rs9273349(T;T)	None	18.6%
792	rs944289(C;C)	None	18.6%	2.6x increased thyroid cancer risk
793	rs1073810(C;T)	None	18.6%
794	rs1124110(A;G)	None	18.6%
795	rs12436436(C;T)	None	18.6%
796	rs12643654(A;G)	None	18.6%
797	rs13182402(A;G)	None	18.6%
798	rs1386496(C;T)	None	18.6%
799	rs1843809(G;T)	None	18.6%
800	rs2050066(C;T)	None	18.6%
801	rs2278871(C;T)	None	18.6%
802	rs2660753(C;T)	None	18.6%
803	rs2681492(A;G)	None	18.6%
804	rs36498(C;T)	None	18.6%
805	rs4741746(C;T)	None	18.6%
806	rs670950(C;T)	None	18.6%
807	rs6787362(A;G)	None	18.6%
808	rs12603332(T;T)	None	18.8%
809	rs2077647(G;G)	None	18.8%
810	rs2289252(T;T)	None	18.8%
811	rs2296603(A;A)	None	18.8%
812	rs4752566(T;T)	None	18.8%
813	rs5937496(A;A)	None	18.8%
814	rs6449176(A;A)	None	18.8%
815	rs6843873(C;C)	None	18.8%
816	rs6849729(C;C)	None	18.8%
817	rs216321(C;T)	None	18.8%
818	rs2608053(A;A)	None	18.9%
819	rs5907577(T;T)	None	18.9%
820	rs7430431(C;C)	None	18.9%
821	rs868903(T;T)	None	18.9%
822	rs903901(A;G)	None	18.9%
823	rs9455973(A;G)	None	18.9%
824	rs4473653(G;G)	None	19.0%
825	rs6852441(T;T)	None	19.0%
826	rs11805657(C;T)	None	19.0%
827	rs1799853(C;T)	None	19.0%	CYP2C9*2 carrier; average 20% reduction in warfarin metabolism
828	rs7771980(C;T)	1.0	19.0%	higher bone mineral density in postmenopausal Spanish women
829	rs2718812(A;A)	None	19.1%
830	rs4621431(A;A)	None	19.1%
831	rs1948368(G;G)	None	19.4%
832	rs7435196(C;C)	None	19.4%
833	rs10021308(A;A)	None	19.5%
834	rs10038113(C;C)	None	19.5%
835	rs10472828(T;T)	None	19.5%
836	rs1143671(T;T)	None	19.5%
837	rs11583804(G;G)	None	19.5%
838	rs12803(T;T)	None	19.5%
839	rs1381102(T;T)	None	19.5%
840	rs179247(G;G)	None	19.5%
841	rs1800378(A;A)	None	19.5%
842	rs2246704(C;C)	None	19.5%
843	rs2257212(A;A)	None	19.5%
844	rs2288774(C;C)	None	19.5%
845	rs2493134(C;C)	None	19.5%
846	rs3731859(G;G)	None	19.5%
847	rs42490(G;G)	None	19.5%
848	rs4311316(A;A)	None	19.5%
849	rs4314284(T;T)	None	19.5%
850	rs4444235(C;C)	None	19.5%
851	rs4455410(C;C)	None	19.5%
852	rs4702473(T;T)	None	19.5%
853	rs4749955(C;C)	None	19.5%
854	rs502396(C;C)	None	19.5%
855	rs5051(T;T)	None	19.5%	normal risk
856	rs6449171(C;C)	None	19.5%
857	rs6449174(T;T)	None	19.5%
858	rs6449178(T;T)	None	19.5%
859	rs6859(A;A)	None	19.5%
860	rs6984526(T;T)	None	19.5%
861	rs699(C;C)	None	19.5%	increased risk of hypertension
862	rs7378340(T;T)	None	19.5%
863	rs763317(A;A)	None	19.5%	3.5x increased lung cancer risk for never-smoking females
864	rs7639752(A;A)	None	19.5%
865	rs7658170(C;C)	None	19.5%
866	rs7769979(A;A)	None	19.5%
867	rs7770628(C;C)	None	19.5%
868	rs893817(G;G)	None	19.5%
869	rs9994266(A;A)	None	19.5%
870	rs10825269(C;T)	None	19.5%
871	rs10919563(A;G)	None	19.5%
872	rs10928195(C;G)	None	19.5%
873	rs11574790(C;T)	None	19.5%
874	rs12257526(C;T)	None	19.5%
875	rs12262754(A;G)	None	19.5%
876	rs12573128(A;G)	None	19.5%
877	rs13027811(A;G)	None	19.5%
878	rs1884136(A;C)	None	19.5%
879	rs2235611(A;G)	None	19.5%
880	rs2292566(A;G)	None	19.5%
881	rs288326(A;G)	None	19.5%
882	rs3020317(C;T)	None	19.5%
883	rs3219156(A;G)	None	19.5%
884	rs3736309(A;G)	None	19.5%	0.44x decreased risk for chronic obstructive pulmonary lung disease
885	rs3745568(A;C)	None	19.5%
886	rs476463(A;G)	None	19.5%
887	rs6830062(C;T)	None	19.5%
888	rs7787531(C;T)	None	19.5%
889	rs1016342(T;T)	None	19.6%
890	rs1057090(T;T)	None	19.6%
891	rs3789243(C;C)	None	19.6%
892	rs6854783(G;G)	None	19.6%
893	rs7686538(T;T)	None	19.6%
894	rs9268877(A;A)	None	19.6%
895	rs6133(G;T)	None	19.6%
896	rs7961894(C;T)	None	19.6%
897	rs9922619(G;G)	None	19.7%
898	rs10259085(C;C)	None	19.8%
899	rs3732359(A;G)	None	19.8%
900	rs1079128(G;G)	None	20.0%
901	rs10818488(G;G)	None	20.0%	normal
902	rs12498150(T;T)	None	20.0%
903	rs4580649(A;A)	None	20.0%
904	rs703965(A;A)	None	20.0%
905	rs7727691(T;T)	None	20.0%
906	rs954353(T;T)	None	20.0%
907	rs9993410(T;T)	None	20.0%
908	rs1048990(C;G)	None	20.0%	1.48x risk
909	rs10885122(G;T)	None	20.0%
910	rs1573496(C;G)	None	20.0%	0.68x decreased risk of oral/throat cancers
911	rs2287499(C;G)	None	20.0%
912	rs2296212(C;G)	None	20.0%
913	rs9253(C;G)	None	20.0%
914	rs13328050(T;T)	None	20.2%
915	rs11572080(A;G)	None	20.2%
916	rs1520724(G;G)	None	20.3%
917	rs1935349(A;G)	None	20.3%
918	rs7915663(A;T)	None	20.3%
919	rs1044396(C;C)	None	20.4%
920	rs1063739(A;A)	None	20.4%
921	rs1127091(T;T)	None	20.4%
922	rs11661542(C;C)	None	20.4%
923	rs1464510(T;T)	None	20.4%
924	rs1799722(T;T)	None	20.4%
925	rs2018643(G;G)	None	20.4%
926	rs2236647(T;T)	None	20.4%
927	rs2412546(A;A)	None	20.4%
928	rs2911968(C;C)	None	20.4%
929	rs3733223(G;G)	None	20.4%
930	rs4598195(C;C)	None	20.4%
931	rs554653(T;T)	None	20.4%
932	rs688(T;T)	None	20.4%	1.5x higher risk for males of Alzheimer's; higher total and LDL cholesterol in females
933	rs885861(C;C)	None	20.4%
934	rs909116(C;C)	None	20.4%
935	rs10831284(A;G)	None	20.4%
936	rs11880198(A;G)	None	20.4%
937	rs12295638(C;T)	None	20.4%
938	rs1343075(C;T)	None	20.4%
939	rs16896068(A;G)	None	20.4%
940	rs17122693(C;T)	None	20.4%
941	rs2020927(C;T)	None	20.4%
942	rs2103868(C;T)	None	20.4%
943	rs2306580(C;G)	None	20.4%
944	rs2373115(G;T)	None	20.4%	normal
945	rs2416879(A;G)	None	20.4%
946	rs2547547(A;G)	None	20.4%
947	rs2863389(C;T)	None	20.4%
948	rs3803915(A;C)	None	20.4%
949	rs4295627(G;T)	None	20.4%
950	rs6569992(A;G)	None	20.4%
951	rs7164503(C;T)	None	20.4%
952	rs9288410(A;G)	None	20.4%
953	rs1141608(T;T)	None	20.5%
954	rs17599222(T;T)	None	20.5%
955	rs2291725(T;T)	None	20.5%
956	rs13551(G;G)	None	20.6%
957	rs2070762(C;C)	None	20.7%
958	rs5751862(A;A)	None	20.7%
959	rs869736(T;T)	None	20.7%
960	rs3125(C;G)	None	20.7%
961	rs1604079(G;G)	None	21.0%
962	rs9862(T;T)	None	21.1%
963	rs1042229(T;T)	None	21.2%
964	rs1058396(A;A)	None	21.2%
965	rs1202184(A;A)	None	21.2%
966	rs12498956(A;A)	None	21.2%
967	rs12658202(C;C)	None	21.2%
968	rs12901499(A;A)	None	21.2%
969	rs1532624(T;T)	None	21.2%
970	rs2040639(G;G)	None	21.2%
971	rs2138852(G;G)	None	21.2%
972	rs2153157(T;T)	None	21.2%
973	rs216293(G;G)	None	21.2%
974	rs2470152(T;T)	None	21.2%
975	rs2736990(C;C)	None	21.2%
976	rs3129109(T;T)	None	21.2%
977	rs3799344(T;T)	None	21.2%
978	rs40457(A;A)	None	21.2%
979	rs4124874(C;C)	None	21.2%
980	rs4934(A;A)	None	21.2%	2.5x increased risk of Azheimer's and decreased age at onset
981	rs643381(A;A)	None	21.2%
982	rs6500882(G;G)	None	21.2%
983	rs680244(A;A)	None	21.2%
984	rs7512898(G;G)	None	21.2%
985	rs8051542(T;T)	None	21.2%
986	rs910316(T;T)	None	21.2%	normal
987	rs9488363(G;G)	None	21.2%
988	rs10498760(A;C)	None	21.2%
989	rs1054135(A;G)	None	21.2%
990	rs10733113(A;G)	None	21.2%
991	rs1158392(C;T)	None	21.2%
992	rs1386493(C;T)	None	21.2%
993	rs1503185(C;T)	None	21.2%
994	rs16909898(A;G)	None	21.2%
995	rs17608766(C;T)	None	21.2%
996	rs2060762(A;G)	None	21.2%
997	rs2217332(C;T)	None	21.2%
998	rs2279463(C;T)	None	21.2%
999	rs337847(A;G)	None	21.2%
1000	rs3740393(C;G)	None	21.2%
1001	rs3769817(A;G)	None	21.2%
1002	rs3934834(C;T)	None	21.2%
1003	rs7513590(A;G)	None	21.2%
1004	rs9657451(A;G)	None	21.2%
1005	rs10876920(T;T)	None	21.4%
1006	rs2097055(T;T)	None	21.4%
1007	rs4399719(G;G)	None	21.4%
1008	rs7817(C;C)	None	21.4%
1009	rs11683229(A;G)	None	21.4%
1010	rs1449683(C;T)	None	21.4%
1011	rs4072111(A;G)	None	21.4%
1012	rs6503691(C;T)	None	21.4%	None
1013	rs891507(C;T)	None	21.4%
1014	rs11642841(C;C)	None	21.5%
1015	rs2856838(T;T)	None	21.5%
1016	rs3803185(A;A)	None	21.5%
1017	rs11746641(G;T)	None	21.5%
1018	rs12613243(C;T)	None	21.5%
1019	rs9317284(G;T)	None	21.5%
1020	rs941601(A;G)	None	21.5%
1021	rs1061624(A;A)	None	21.6%
1022	rs2592887(A;A)	None	21.6%
1023	rs726455(C;C)	None	21.6%
1024	rs12100561(A;G)	None	21.6%
1025	rs10017674(C;C)	None	21.7%
1026	rs4810685(C;C)	None	21.7%
1027	rs11571323(A;G)	None	21.7%
1028	rs2134143(G;G)	None	21.9%
1029	rs4767551(C;C)	None	21.9%
1030	rs7163283(A;A)	None	21.9%
1031	rs9937053(G;G)	None	22.0%
1032	rs1042523(A;A)	None	22.1%
1033	rs10955924(A;A)	None	22.1%
1034	rs1165196(C;C)	None	22.1%
1035	rs1165215(C;C)	None	22.1%
1036	rs12368653(A;A)	None	22.1%
1037	rs1382269(C;C)	None	22.1%
1038	rs1492820(C;C)	None	22.1%
1039	rs1529729(G;G)	None	22.1%
1040	rs1800792(G;G)	None	22.1%
1041	rs1902341(A;A)	None	22.1%
1042	rs227731(A;A)	None	22.1%
1043	rs2294478(T;T)	None	22.1%
1044	rs2315504(C;C)	None	22.1%
1045	rs266717(G;G)	None	22.1%
1046	rs2839619(A;A)	None	22.1%
1047	rs2872507(A;A)	None	22.1%
1048	rs4549631(C;C)	None	22.1%
1049	rs4743056(C;C)	None	22.1%
1050	rs4947339(T;T)	None	22.1%
1051	rs6589964(A;A)	None	22.1%
1052	rs907092(A;A)	None	22.1%
1053	rs1036819(A;C)	None	22.1%
1054	rs1042114(G;T)	None	22.1%
1055	rs10500991(C;T)	None	22.1%
1056	rs10509681(C;T)	None	22.1%
1057	rs10847697(A;G)	None	22.1%
1058	rs12720208(C;T)	None	22.1%
1059	rs1385374(C;T)	None	22.1%
1060	rs1566734(G;T)	None	22.1%
1061	rs16956936(C;T)	None	22.1%
1062	rs1886449(C;T)	None	22.1%
1063	rs2735839(A;G)	None	22.1%
1064	rs2867125(A;G)	None	22.1%
1065	rs3093135(A;T)	None	22.1%
1066	rs3793336(C;T)	None	22.1%
1067	rs4238010(A;G)	None	22.1%
1068	rs4854344(G;T)	None	22.1%
1069	rs6951030(G;T)	None	22.1%
1070	rs6959888(A;G)	None	22.1%
1071	rs7561317(A;G)	None	22.1%
1072	rs9284813(A;G)	None	22.1%
1073	rs10774929(G;G)	None	22.2%
1074	rs4980524(G;G)	None	22.2%
1075	rs628751(A;A)	None	22.2%
1076	rs11605924(A;C)	None	22.2%
1077	rs11920090(A;T)	None	22.2%
1078	rs2491397(C;C)	None	22.3%
1079	rs1018040(A;T)	None	22.3%
1080	rs3766404(C;T)	None	22.3%
1081	rs7801086(G;T)	None	22.3%
1082	rs7912161(A;G)	None	22.4%
1083	rs2303063(A;A)	None	22.5%
1084	rs2841307(A;G)	None	22.5%
1085	rs4646580(C;C)	None	22.6%
1086	rs10919071(A;G)	None	22.6%
1087	rs2071559(C;C)	None	22.7%
1088	rs6548238(C;T)	None	22.7%
1089	rs1003483(G;G)	None	23.0%
1090	rs10108011(G;G)	None	23.0%
1091	rs10517437(A;A)	None	23.0%
1092	rs10903122(G;G)	None	23.0%
1093	rs11247226(G;G)	None	23.0%
1094	rs12129861(A;A)	None	23.0%
1095	rs1533317(C;C)	None	23.0%
1096	rs2494262(C;C)	None	23.0%
1097	rs2607737(T;T)	None	23.0%
1098	rs3925584(G;G)	None	23.0%
1099	rs4580814(G;G)	None	23.0%
1100	rs4837628(C;C)	None	23.0%
1101	rs5743810(T;T)	None	23.0%
1102	rs744910(G;G)	None	23.0%
1103	rs7631540(T;T)	None	23.0%
1104	rs7647307(G;G)	None	23.0%
1105	rs8067378(G;G)	None	23.0%
1106	rs875643(T;T)	None	23.0%
1107	rs9303277(T;T)	None	23.0%
1108	rs1058205(C;T)	None	23.0%
1109	rs10846744(C;G)	None	23.0%
1110	rs1136410(C;T)	None	23.0%	0.80x reduced risk for glioblastoma
1111	rs11706052(A;G)	None	23.0%
1112	rs1385600(C;T)	None	23.0%
1113	rs1539243(C;T)	None	23.0%
1114	rs2140148(G;T)	None	23.0%
1115	rs2336219(A;G)	None	23.0%
1116	rs2826340(A;T)	None	23.0%
1117	rs3127573(C;T)	None	23.0%
1118	rs3770748(C;T)	None	23.0%	1.26x risk for lower bone mineral density
1119	rs3935591(A;G)	None	23.0%	usually brown eye color
1120	rs6791599(A;G)	None	23.0%
1121	rs7101429(A;G)	None	23.0%	0.70x reduced risk for Alzheimer's risk
1122	rs735482(A;C)	None	23.0%
1123	rs966365(C;T)	None	23.0%
1124	rs498177(C;C)	None	23.1%
1125	rs10509637(A;G)	None	23.1%
1126	rs1052756(C;T)	None	23.1%
1127	rs17484721(A;G)	None	23.1%
1128	rs2168631(A;G)	None	23.1%
1129	rs2208454(G;T)	None	23.1%
1130	rs2245218(A;G)	None	23.1%
1131	rs6836703(A;G)	None	23.1%	1.34x increased risk for azoospermia in males
1132	rs7723605(C;T)	None	23.1%
1133	rs1805034(T;T)	None	23.2%
1134	rs7445013(A;A)	None	23.2%
1135	rs4945261(A;G)	None	23.2%
1136	rs6808835(G;T)	None	23.2%
1137	rs4874147(C;C)	None	23.3%
1138	rs2287074(G;G)	None	23.4%
1139	rs38855(A;A)	None	23.4%
1140	rs6942930(G;G)	None	23.4%
1141	rs763014(C;C)	None	23.4%
1142	rs9296669(A;A)	None	23.4%
1143	rs161927(A;G)	None	23.4%
1144	rs8008319(A;T)	None	23.4%
1145	rs10896449(A;A)	None	23.6%
1146	rs4305745(G;G)	None	23.8%
1147	rs10759932(C;T)	None	23.8%	increased risk for chorionic plate inflammation
1148	rs10760130(A;A)	None	23.9%
1149	rs1165176(T;T)	None	23.9%
1150	rs1233560(T;T)	None	23.9%
1151	rs12612347(A;A)	None	23.9%
1152	rs1522232(C;C)	None	23.9%
1153	rs1954787(C;C)	None	23.9%	~10% more likely to respond to citalopram
1154	rs2013938(G;G)	None	23.9%
1155	rs2134142(A;A)	None	23.9%
1156	rs2227631(A;A)	None	23.9%
1157	rs2227928(C;C)	None	23.9%	poorer response to pancreatic cancer combined treatment
1158	rs2290400(G;G)	None	23.9%
1159	rs2290532(C;C)	None	23.9%
1160	rs2411759(T;T)	None	23.9%
1161	rs2821557(T;T)	None	23.9%
1162	rs2959802(C;C)	None	23.9%
1163	rs337663(G;G)	None	23.9%
1164	rs4792394(A;A)	None	23.9%
1165	rs531676(T;T)	None	23.9%
1166	rs6426833(A;A)	None	23.9%
1167	rs6507931(C;C)	None	23.9%
1168	rs6993813(C;C)	None	23.9%
1169	rs77905(T;T)	None	23.9%
1170	rs7931342(T;T)	None	23.9%
1171	rs8878(C;C)	None	23.9%
1172	rs10279573(C;T)	None	23.9%
1173	rs1049296(C;T)	None	23.9%
1174	rs12580100(A;G)	None	23.9%
1175	rs13192471(C;T)	None	23.9%
1176	rs1983853(C;T)	None	23.9%
1177	rs2614046(C;T)	None	23.9%
1178	rs2905072(C;T)	None	23.9%
1179	rs3077(C;T)	None	23.9%
1180	rs3102735(C;T)	None	23.9%
1181	rs568408(A;G)	None	23.9%
1182	rs6565681(A;G)	None	23.9%
1183	rs8074995(A;G)	None	23.9%
1184	rs2002842(C;C)	None	24.1%
1185	rs2109075(C;C)	None	24.1%
1186	rs2549782(G;G)	None	24.1%
1187	rs3807306(C;C)	None	24.1%
1188	rs8007846(G;G)	None	24.1%
1189	rs9940128(G;G)	None	24.1%
1190	rs11594(A;C)	None	24.1%
1191	rs6672995(A;G)	None	24.1%
1192	rs3025343(A;G)	None	24.2%
1193	rs1034825(T;T)	None	24.6%
1194	rs11788456(G;G)	None	24.6%
1195	rs2664170(G;G)	None	24.6%
1196	rs2715148(A;A)	None	24.6%
1197	rs3761548(A;A)	None	24.6%
1198	rs7785088(A;A)	None	24.6%
1199	rs944722(T;T)	None	24.6%
1200	rs12225230(C;G)	None	24.6%
1201	rs16966460(C;G)	None	24.6%
1202	rs1800863(C;G)	None	24.6%
1203	rs10336(C;C)	None	24.8%
1204	rs1053266(C;C)	None	24.8%
1205	rs10784496(G;G)	None	24.8%
1206	rs10982256(C;C)	None	24.8%	1.5x risk
1207	rs12453407(G;G)	None	24.8%
1208	rs1478486(T;T)	None	24.8%
1209	rs1601875(T;T)	None	24.8%
1210	rs17122021(T;T)	None	24.8%
1211	rs1867504(G;G)	None	24.8%
1212	rs2228611(G;G)	None	24.8%
1213	rs2425637(T;T)	None	24.8%
1214	rs2834072(A;A)	None	24.8%
1215	rs3747676(T;T)	None	24.8%
1216	rs41464348(T;T)	None	24.8%
1217	rs4802234(T;T)	None	24.8%
1218	rs4917623(C;C)	None	24.8%
1219	rs571118(A;A)	None	24.8%
1220	rs6332(A;A)	None	24.8%
1221	rs6465657(C;C)	None	24.8%
1222	rs6469792(C;C)	None	24.8%
1223	rs7853123(G;G)	None	24.8%
1224	rs788016(G;G)	None	24.8%
1225	rs806377(T;T)	None	24.8%
1226	rs9310709(C;C)	None	24.8%
1227	rs953413(G;G)	None	24.8%
1228	rs9939973(G;G)	None	24.8%
1229	rs10506701(A;C)	None	24.8%
1230	rs10511089(G;T)	None	24.8%
1231	rs10521329(A;C)	None	24.8%
1232	rs10867752(C;T)	None	24.8%
1233	rs11703684(C;T)	None	24.8%
1234	rs12279261(A;G)	None	24.8%
1235	rs12487452(C;G)	None	24.8%
1236	rs1342326(G;T)	None	24.8%
1237	rs1805015(C;T)	None	24.8%
1238	rs2075650(A;G)	None	24.8%	2x higher Alzheimer's risk
1239	rs2216228(C;T)	None	24.8%
1240	rs2269529(C;T)	None	24.8%
1241	rs2697962(A;G)	None	24.8%
1242	rs4837192(A;G)	None	24.8%
1243	rs4916176(A;C)	None	24.8%
1244	rs4979906(A;G)	None	24.8%
1245	rs7191888(A;G)	None	24.8%
1246	rs754554(A;C)	None	24.8%
1247	rs871392(A;G)	None	24.8%
1248	rs9891572(C;T)	None	24.8%
1249	rs10069397(C;C)	None	25.0%
1250	rs1042615(C;C)	None	25.0%
1251	rs12443621(A;A)	None	25.0%
1252	rs13103879(C;C)	None	25.0%
1253	rs186660(C;C)	None	25.0%
1254	rs1884444(T;T)	None	25.0%
1255	rs291353(G;G)	None	25.0%
1256	rs365132(T;T)	None	25.0%
1257	rs4775671(A;A)	None	25.0%
1258	rs7561273(G;G)	None	25.0%
1259	rs9941349(C;C)	None	25.0%
1260	rs11554257(C;T)	None	25.0%
1261	rs1800624(A;T)	None	25.0%
1262	rs2073048(C;T)	None	25.0%
1263	rs2621215(G;T)	None	25.0%
1264	rs795009(A;C)	None	25.0%
1265	rs9483788(C;T)	None	25.0%
1266	rs4633(T;T)	None	25.2%	higher risk for endometrial cancer
1267	rs4646642(C;C)	None	25.2%
1268	rs521018(C;C)	None	25.2%
1269	rs5760410(A;A)	None	25.2%
1270	rs2278293(G;G)	None	25.4%
1271	rs8179673(C;T)	None	25.4%
1272	rs498207(C;C)	None	25.5%
1273	rs11666377(C;T)	None	25.5%
1274	rs10749535(C;C)	None	25.7%
1275	rs11089788(A;A)	None	25.7%
1276	rs11201985(G;G)	None	25.7%
1277	rs1426310(A;A)	None	25.7%
1278	rs1497571(A;A)	None	25.7%
1279	rs1800775(A;A)	None	25.7%
1280	rs2030926(C;C)	None	25.7%
1281	rs2395402(T;T)	None	25.7%
1282	rs2413450(C;C)	None	25.7%
1283	rs2444217(T;T)	None	25.7%
1284	rs280519(G;G)	None	25.7%
1285	rs3814614(C;C)	None	25.7%
1286	rs448378(A;A)	None	25.7%
1287	rs6693882(G;G)	None	25.7%
1288	rs6782400(A;A)	None	25.7%
1289	rs6927022(A;A)	None	25.7%
1290	rs7201(A;A)	None	25.7%
1291	rs7278737(T;T)	None	25.7%
1292	rs757863(A;A)	None	25.7%
1293	rs7626693(T;T)	None	25.7%
1294	rs9370096(A;A)	None	25.7%
1295	rs10512597(C;T)	None	25.7%
1296	rs11071559(C;T)	None	25.7%
1297	rs12472911(C;T)	None	25.7%
1298	rs16886165(G;T)	None	25.7%
1299	rs1874326(A;G)	None	25.7%
1300	rs2229416(A;G)	None	25.7%
1301	rs2322659(C;T)	None	25.7%
1302	rs2327832(A;G)	None	25.7%
1303	rs2335052(A;G)	None	25.7%
1304	rs2532105(C;T)	None	25.7%
1305	rs2966952(C;T)	None	25.7%
1306	rs308395(C;G)	None	25.7%
1307	rs3732360(C;T)	None	25.7%
1308	rs374748(A;G)	None	25.7%
1309	rs577912(A;C)	None	25.7%
1310	rs579327(A;G)	None	25.7%
1311	rs643780(A;G)	None	25.7%
1312	rs648202(C;T)	None	25.7%
1313	rs650439(A;T)	None	25.7%
1314	rs7557078(A;C)	None	25.7%
1315	rs7717527(A;G)	None	25.7%
1316	rs7980470(A;G)	None	25.7%
1317	rs8083511(A;C)	None	25.7%
1318	rs871840(A;G)	None	25.7%
1319	rs9465871(C;T)	None	25.7%	1.2x risk type-2 diabetes
1320	rs4973768(C;C)	None	25.9%
1321	rs761100(G;G)	None	25.9%	higher risk for dyslexia
1322	rs7848524(C;C)	None	25.9%
1323	rs1333026(A;G)	None	25.9%
1324	rs1863080(A;C)	None	25.9%
1325	rs2206734(A;G)	None	25.9%
1326	rs2244621(A;G)	None	25.9%
1327	rs25673(A;G)	None	25.9%
1328	rs4754373(C;T)	None	25.9%
1329	rs6493497(A;G)	None	25.9%
1330	rs6710341(A;G)	None	25.9%	haplotype at risk for restless legs
1331	rs7647305(C;T)	None	25.9%
1332	rs1540771(A;A)	None	26.1%
1333	rs12043633(A;G)	None	26.1%
1334	rs3784609(A;G)	None	26.1%
1335	rs10008257(G;G)	None	26.2%
1336	rs10499859(A;A)	None	26.2%
1337	rs2248814(G;G)	None	26.2%
1338	rs231362(C;C)	None	26.2%
1339	rs3760138(T;T)	None	26.2%
1340	rs4416533(T;T)	None	26.2%
1341	rs4898820(G;G)	None	26.2%
1342	rs7435827(A;A)	None	26.2%
1343	rs11889341(C;T)	None	26.2%
1344	rs2273535(A;T)	None	26.2%	higher cancer risk
1345	rs3091367(C;G)	None	26.2%
1346	rs1383139(T;T)	None	26.5%
1347	rs1441586(C;C)	None	26.5%
1348	rs1480090(T;T)	None	26.5%
1349	rs1780324(T;T)	None	26.5%
1350	rs2300045(C;C)	None	26.5%
1351	rs2567608(G;G)	None	26.5%
1352	rs2587695(A;A)	None	26.5%
1353	rs3751812(G;G)	None	26.5%	normal
1354	rs3767489(A;A)	None	26.5%
1355	rs3894194(C;C)	None	26.5%
1356	rs502581(A;A)	None	26.5%
1357	rs560426(A;A)	None	26.5%
1358	rs6979(A;A)	None	26.5%
1359	rs7671167(T;T)	None	26.5%
1360	rs8072199(C;C)	None	26.5%
1361	rs9436640(G;G)	None	26.5%
1362	rs948962(G;G)	None	26.5%
1363	rs1047031(A;G)	None	26.5%	normal
1364	rs11144766(C;T)	None	26.5%
1365	rs12203592(C;T)	None	26.5%
1366	rs2081670(A;G)	None	26.5%
1367	rs2143571(A;G)	None	26.5%
1368	rs2184026(C;T)	None	26.5%
1369	rs2229840(A;G)	None	26.5%
1370	rs224136(C;T)	None	26.5%
1371	rs2267013(A;G)	None	26.5%	1.3x increased risk for depression
1372	rs2331291(C;T)	None	26.5%
1373	rs2453839(C;T)	None	26.5%
1374	rs2562784(C;T)	None	26.5%
1375	rs290481(A;G)	None	26.5%
1376	rs299284(C;T)	None	26.5%
1377	rs3127162(C;T)	None	26.5%
1378	rs3130342(G;T)	None	26.5%
1379	rs3826656(A;G)	None	26.5%
1380	rs396230(A;G)	None	26.5%
1381	rs412050(C;G)	None	26.5%
1382	rs4675374(C;T)	None	26.5%
1383	rs526906(C;T)	None	26.5%
1384	rs541041(C;T)	None	26.5%
1385	rs553668(C;T)	None	26.5%
1386	rs562338(C;T)	None	26.5%
1387	rs6845865(C;T)	None	26.5%
1388	rs744016(A;G)	None	26.5%
1389	rs7595412(A;G)	None	26.5%
1390	rs7730843(A;G)	None	26.5%
1391	rs8015016(A;G)	None	26.5%
1392	rs916977(A;G)	None	26.5%	usually brown eye color
1393	rs9895661(C;T)	None	26.5%
1394	rs12197043(A;A)	None	26.6%
1395	rs2958832(A;G)	None	26.6%
1396	rs10757283(C;C)	None	26.8%
1397	rs1485766(C;C)	None	26.8%
1398	rs3804099(T;T)	None	26.8%
1399	rs4803455(A;A)	None	26.8%
1400	rs893971(T;T)	None	26.8%
1401	rs1042034(A;G)	None	26.8%
1402	rs10895959(A;A)	None	26.9%
1403	rs4466998(C;C)	None	26.9%
1404	rs1130496(G;G)	None	27.0%
1405	rs2504106(T;T)	None	27.0%
1406	rs7193144(T;T)	None	27.0%
1407	rs1667394(A;G)	None	27.0%
1408	rs2746073(A;T)	None	27.0%
1409	rs562556(A;G)	None	27.0%
1410	rs8133052(A;A)	None	27.3%
1411	rs10038196(T;T)	None	27.4%
1412	rs1227756(A;A)	None	27.4%
1413	rs1372857(A;A)	None	27.4%
1414	rs1529093(C;C)	None	27.4%
1415	rs1561570(T;T)	None	27.4%
1416	rs1802710(T;T)	None	27.4%
1417	rs1875517(C;C)	None	27.4%
1418	rs198388(C;C)	None	27.4%
1419	rs2075685(T;T)	None	27.4%
1420	rs2357928(G;G)	None	27.4%
1421	rs2380205(C;C)	None	27.4%
1422	rs3110697(G;G)	None	27.4%
1423	rs3784259(A;A)	None	27.4%
1424	rs405509(A;A)	None	27.4%
1425	rs721575(A;A)	None	27.4%
1426	rs7650365(G;G)	None	27.4%
1427	rs8016947(G;G)	None	27.4%
1428	rs837763(G;G)	None	27.4%
1429	rs886427(A;A)	None	27.4%
1430	rs9395066(A;A)	None	27.4%
1431	rs1044516(A;C)	None	27.4%
1432	rs10934491(A;C)	None	27.4%
1433	rs11628713(C;T)	None	27.4%
1434	rs12029454(A;G)	None	27.4%
1435	rs1427407(G;T)	None	27.4%
1436	rs1721400(C;T)	None	27.4%
1437	rs1879282(C;T)	None	27.4%
1438	rs1884614(C;T)	None	27.4%
1439	rs2144908(A;G)	None	27.4%
1440	rs2213177(A;G)	None	27.4%
1441	rs2402130(A;G)	None	27.4%
1442	rs2729409(A;G)	None	27.4%
1443	rs2994684(C;T)	None	27.4%
1444	rs4857855(C;T)	None	27.4%
1445	rs613872(G;T)	None	27.4%
1446	rs6847149(A;G)	None	27.4%
1447	rs766432(A;C)	None	27.4%
1448	rs10516541(G;G)	None	27.7%
1449	rs1108580(G;G)	None	27.7%
1450	rs1203981(C;C)	None	27.7%
1451	rs1697421(G;G)	None	27.7%
1452	rs17181170(G;G)	None	27.7%
1453	rs7091565(C;C)	None	27.7%
1454	rs8756(C;C)	None	27.7%
1455	rs10181656(C;G)	None	27.7%	1.7x increased SLE risk
1456	rs1113129(C;G)	None	27.7%
1457	rs11718863(A;T)	None	27.7%	1.43x increased osteoarthritis risk
1458	rs12474609(A;T)	None	27.7%
1459	rs167715(C;T)	None	27.7%
1460	rs1800449(A;G)	None	27.7%
1461	rs2049045(C;G)	None	27.7%
1462	rs2073485(A;G)	None	27.7%
1463	rs6920220(A;G)	None	27.7%	1.2x risk
1464	rs7708392(C;G)	None	27.7%
1465	rs8069344(A;T)	None	27.7%
1466	rs8191754(C;G)	None	27.7%
1467	rs921146(A;C)	None	27.7%
1468	rs2461483(C;C)	None	27.9%
1469	rs2070016(C;T)	None	27.9%
1470	rs6136489(G;T)	None	27.9%
1471	rs10865035(G;G)	None	28.1%
1472	rs1165153(T;T)	None	28.1%
1473	rs186715(A;A)	None	28.1%
1474	rs4897081(G;G)	None	28.1%
1475	rs7776054(A;G)	None	28.1%
1476	rs2301523(A;G)	None	28.2%
1477	rs10188217(T;T)	None	28.3%
1478	rs10490823(A;A)	None	28.3%
1479	rs11728697(T;T)	None	28.3%
1480	rs12075(A;A)	None	28.3%
1481	rs1344142(A;A)	None	28.3%
1482	rs1364063(T;T)	None	28.3%
1483	rs1458175(G;G)	None	28.3%
1484	rs1930095(A;A)	None	28.3%
1485	rs1967017(C;C)	None	28.3%
1486	rs203332(G;G)	None	28.3%
1487	rs2537859(C;C)	None	28.3%
1488	rs2538976(G;G)	None	28.3%	higher risk for speech development delay and/or impairment
1489	rs3756648(C;C)	None	28.3%
1490	rs440299(A;A)	None	28.3%
1491	rs6469804(A;A)	None	28.3%
1492	rs851982(T;T)	None	28.3%
1493	rs9502893(T;T)	None	28.3%
1494	rs9530(C;C)	None	28.3%
1495	rs11558492(C;T)	None	28.3%
1496	rs13188771(A;C)	None	28.3%
1497	rs1424941(A;G)	None	28.3%
1498	rs1557488(A;G)	None	28.3%
1499	rs167771(A;G)	None	28.3%
1500	rs1801968(C;G)	None	28.3%
1501	rs1879352(A;G)	None	28.3%
1502	rs2067980(A;G)	None	28.3%
1503	rs2162440(C;T)	None	28.3%
1504	rs2218488(C;T)	None	28.3%
1505	rs2305560(C;T)	None	28.3%
1506	rs2326458(A;C)	None	28.3%
1507	rs2660899(G;T)	None	28.3%
1508	rs2767485(C;T)	None	28.3%
1509	rs2835762(C;T)	None	28.3%
1510	rs3129900(G;T)	None	28.3%
1511	rs34677(G;T)	None	28.3%
1512	rs4778241(A;C)	None	28.3%	usually brown eye color
1513	rs5028798(G;T)	None	28.3%
1514	rs676210(A;G)	None	28.3%
1515	rs6809854(A;G)	None	28.3%
1516	rs7235755(A;G)	None	28.3%
1517	rs7639618(C;T)	None	28.3%	1.45x increased osteoarthritis risk
1518	rs973968(A;G)	None	28.3%
1519	rs1799939(A;G)	None	28.4%
1520	rs1018326(A;A)	None	28.6%
1521	rs10772420(A;A)	None	28.6%
1522	rs10815798(A;A)	None	28.6%
1523	rs1550922(G;G)	None	28.6%
1524	rs2250417(G;G)	None	28.6%
1525	rs2334499(C;C)	None	28.6%
1526	rs2738459(A;A)	None	28.6%
1527	rs324640(G;G)	None	28.6%	normal. rare for asians.
1528	rs4355801(A;A)	None	28.6%
1529	rs4732682(C;C)	None	28.6%
1530	rs821577(T;T)	None	28.6%
1531	rs10494994(A;G)	None	28.6%
1532	rs12779790(A;G)	None	28.6%
1533	rs1800855(A;T)	None	28.6%
1534	rs284787(C;T)	None	28.6%
1535	rs3129934(C;T)	None	28.6%	normal
1536	rs3800855(C;G)	None	28.6%
1537	rs4844880(A;T)	None	28.6%
1538	rs6007413(C;G)	None	28.6%
1539	rs673548(A;G)	None	28.6%
1540	rs2237717(C;C)	None	28.8%
1541	rs6056209(G;G)	None	28.8%
1542	rs7907713(A;G)	None	28.8%
1543	rs13131226(C;T)	None	29.0%
1544	rs1045642(T;T)	None	29.2%
1545	rs1052576(A;A)	None	29.2%
1546	rs10769908(C;C)	None	29.2%
1547	rs10845840(C;C)	None	29.2%
1548	rs11205277(A;A)	None	29.2%
1549	rs11249206(T;T)	None	29.2%
1550	rs1149374(C;C)	None	29.2%
1551	rs12198986(A;A)	None	29.2%
1552	rs1449263(A;A)	None	29.2%
1553	rs1529316(C;C)	None	29.2%
1554	rs1572299(G;G)	None	29.2%
1555	rs17586674(A;A)	None	29.2%
1556	rs198389(A;A)	None	29.2%
1557	rs2042370(C;C)	None	29.2%
1558	rs2072621(A;A)	None	29.2%
1559	rs2284017(C;C)	None	29.2%
1560	rs2312147(C;C)	None	29.2%
1561	rs2494251(G;G)	None	29.2%
1562	rs2710102(C;C)	None	29.2%	higher risk of speech development delay and/or impairment
1563	rs2836823(C;C)	None	29.2%
1564	rs2878172(G;G)	None	29.2%
1565	rs3761218(T;T)	None	29.2%	normal
1566	rs3812718(T;T)	None	29.2%
1567	rs470490(T;T)	None	29.2%
1568	rs4764695(G;G)	None	29.2%
1569	rs4939827(C;C)	None	29.2%	0.73x decreased risk for colorectal cancer
1570	rs737030(T;T)	None	29.2%
1571	rs737622(A;A)	None	29.2%
1572	rs7439293(A;A)	None	29.2%	increased risk of coronary heart disease; better response to statins
1573	rs9291683(G;G)	None	29.2%
1574	rs941815(G;G)	None	29.2%
1575	rs951436(A;A)	None	29.2%
1576	rs10510837(A;G)	None	29.2%
1577	rs10767942(C;T)	None	29.2%
1578	rs10975200(A;G)	None	29.2%
1579	rs11672433(A;G)	None	29.2%
1580	rs12050217(A;G)	None	29.2%
1581	rs12722489(A;G)	None	29.2%
1582	rs17152408(A;G)	None	29.2%
1583	rs17152411(A;G)	None	29.2%
1584	rs1887427(A;G)	None	29.2%
1585	rs1975197(C;T)	None	29.2%	1.3x increased risk for restless legs syndrome
1586	rs206936(A;G)	None	29.2%
1587	rs2070995(A;G)	None	29.2%
1588	rs2075263(C;T)	None	29.2%
1589	rs222020(C;T)	None	29.2%
1590	rs2281135(C;T)	None	29.2%
1591	rs2284689(C;T)	None	29.2%
1592	rs2306180(C;T)	None	29.2%
1593	rs2636797(C;T)	None	29.2%
1594	rs278600(A;C)	None	29.2%
1595	rs2967605(A;G)	None	29.2%
1596	rs3758653(C;T)	None	29.2%
1597	rs441051(C;T)	None	29.2%
1598	rs463426(C;T)	None	29.2%
1599	rs6481464(C;T)	None	29.2%
1600	rs6929846(C;T)	None	29.2%
1601	rs7086128(A;G)	None	29.2%
1602	rs7544736(A;G)	None	29.2%
1603	rs7900929(A;C)	None	29.2%
1604	rs8070473(G;T)	None	29.2%
1605	rs930395(C;T)	None	29.2%
1606	rs9402686(A;G)	None	29.2%
1607	rs9494145(C;T)	None	29.2%
1608	rs952621(C;T)	None	29.2%
1609	rs10776612(C;C)	None	29.4%
1610	rs2518136(C;C)	None	29.5%
1611	rs2661319(A;A)	None	29.5%
1612	rs383362(T;T)	None	29.5%
1613	rs441399(T;T)	None	29.5%
1614	rs734232(G;G)	None	29.5%
1615	rs759178(G;G)	None	29.5%	higher risk of speech development delay and/or impairment
1616	rs1801159(A;G)	None	29.5%
1617	rs1812175(C;T)	None	29.5%
1618	rs2762051(C;T)	None	29.5%
1619	rs6022(G;T)	None	29.5%
1620	rs6544718(C;T)	None	29.5%
1621	rs9271366(A;G)	None	29.5%
1622	rs1405209(A;A)	None	29.7%
1623	rs1450099(C;C)	None	29.7%
1624	rs2184898(G;G)	None	29.7%
1625	rs2540917(A;A)	None	29.7%
1626	rs4390941(T;T)	None	29.7%
1627	rs1986655(A;G)	None	29.7%
1628	rs2554380(C;T)	None	29.7%
1629	rs3745925(G;T)	None	29.7%
1630	rs750749(C;T)	None	29.7%
1631	rs10918270(G;G)	None	30.0%
1632	rs2072493(A;G)	None	30.0%
1633	rs10761581(T;T)	None	30.1%
1634	rs132985(C;C)	None	30.1%
1635	rs1383914(A;A)	None	30.1%
1636	rs16147(G;G)	None	30.1%
1637	rs17337252(G;G)	None	30.1%
1638	rs1801018(A;A)	None	30.1%
1639	rs180223(T;T)	None	30.1%
1640	rs1927702(T;T)	None	30.1%
1641	rs193688(T;T)	None	30.1%
1642	rs1941958(G;G)	None	30.1%
1643	rs2069550(T;T)	None	30.1%
1644	rs2070633(C;C)	None	30.1%
1645	rs2116078(G;G)	None	30.1%
1646	rs2227684(G;G)	None	30.1%
1647	rs2292399(A;A)	None	30.1%
1648	rs2499604(G;G)	None	30.1%
1649	rs281868(T;T)	None	30.1%
1650	rs2937639(G;G)	None	30.1%
1651	rs4072037(A;A)	None	30.1%
1652	rs4704560(C;C)	None	30.1%
1653	rs4919908(C;C)	None	30.1%
1654	rs4919910(C;C)	None	30.1%
1655	rs492602(C;C)	None	30.1%	higher B12 levels in women
1656	rs6017342(C;C)	None	30.1%
1657	rs6442522(C;C)	None	30.1%
1658	rs654136(G;G)	None	30.1%
1659	rs7157940(T;T)	None	30.1%
1660	rs7242(T;T)	None	30.1%
1661	rs743446(G;G)	None	30.1%
1662	rs7580332(A;A)	None	30.1%
1663	rs7974925(G;G)	None	30.1%
1664	rs853326(T;T)	None	30.1%
1665	rs87938(G;G)	None	30.1%
1666	rs1052773(A;G)	None	30.1%
1667	rs10810865(C;T)	None	30.1%
1668	rs12425791(A;G)	None	30.1%	mixed evidence of increased risk for stroke 1.3x increased risk for stroke in an initial study, but failed to replicate in a followup.
1669	rs17690122(A;G)	None	30.1%
1670	rs1867137(C;T)	None	30.1%
1671	rs1867138(C;T)	None	30.1%
1672	rs2230912(A;G)	None	30.1%
1673	rs2306402(C;T)	None	30.1%	1.18x increased risk for LOAD
1674	rs294636(A;C)	None	30.1%
1675	rs4143832(A;C)	None	30.1%
1676	rs490592(G;T)	None	30.1%
1677	rs6118083(A;G)	None	30.1%
1678	rs6138150(C;T)	None	30.1%
1679	rs6754295(G;T)	None	30.1%
1680	rs7905537(A;C)	None	30.1%
1681	rs9818870(C;T)	None	30.1%
1682	rs1709544(T;T)	None	30.2%
1683	rs7013278(C;T)	None	30.2%
1684	rs10812610(A;A)	None	30.4%
1685	rs12364988(T;T)	None	30.4%
1686	rs12373237(A;A)	None	30.4%
1687	rs131690(G;G)	None	30.4%	1.5x increased risk for bipolar disorder
1688	rs1376877(T;T)	None	30.4%
1689	rs2287076(T;T)	None	30.4%
1690	rs2709736(G;G)	None	30.4%
1691	rs40184(G;G)	None	30.4%
1692	rs573514(T;T)	None	30.4%
1693	rs752637(G;G)	None	30.4%
1694	rs808225(A;A)	None	30.4%
1695	rs10243024(A;G)	None	30.4%
1696	rs11684747(A;G)	None	30.4%
1697	rs331(A;G)	None	30.4%
1698	rs4086116(C;T)	None	30.4%
1699	rs6766709(A;T)	None	30.4%
1700	rs3109894(G;G)	None	30.6%
1701	rs6914091(C;C)	None	30.6%
1702	rs9871556(T;T)	None	30.6%
1703	rs1403543(G;G)	None	30.8%
1704	rs1739843(C;C)	None	30.8%
1705	rs2179652(T;T)	None	30.8%
1706	rs2442728(C;C)	None	30.8%
1707	rs10263447(C;G)	None	30.8%
1708	rs10507130(A;G)	None	30.8%
1709	rs4956302(A;G)	None	30.8%
1710	rs6484176(C;T)	None	30.8%
1711	rs7586898(C;G)	None	30.8%
1712	rs4544423(G;G)	None	30.9%
1713	rs2309428(A;C)	None	30.9%
1714	rs805722(C;T)	None	30.9%
1715	rs10489615(G;G)	None	31.0%
1716	rs10983320(C;C)	None	31.0%
1717	rs17300741(G;G)	None	31.0%
1718	rs1800682(T;T)	None	31.0%
1719	rs1937845(T;T)	None	31.0%
1720	rs2036914(C;C)	None	31.0%
1721	rs2069727(A;A)	None	31.0%
1722	rs212388(A;A)	None	31.0%
1723	rs2235544(A;A)	None	31.0%
1724	rs2274064(T;T)	None	31.0%
1725	rs234720(C;C)	None	31.0%
1726	rs237484(C;C)	None	31.0%
1727	rs2550948(A;A)	None	31.0%
1728	rs2637777(T;T)	None	31.0%
1729	rs3729508(G;G)	None	31.0%
1730	rs7554607(A;A)	None	31.0%
1731	rs8040868(T;T)	None	31.0%
1732	rs825411(C;C)	None	31.0%
1733	rs909486(C;C)	None	31.0%
1734	rs934734(T;T)	None	31.0%
1735	rs9386463(G;G)	None	31.0%
1736	rs9536591(A;A)	None	31.0%
1737	rs979233(G;G)	None	31.0%
1738	rs10011926(C;T)	None	31.0%
1739	rs1039302(C;T)	None	31.0%
1740	rs10761482(C;T)	None	31.0%
1741	rs11045819(A;C)	None	31.0%
1742	rs1106683(A;G)	None	31.0%
1743	rs1106684(C;G)	None	31.0%
1744	rs1143634(C;T)	None	31.0%	complex; see details
1745	rs12079081(A;G)	None	31.0%
1746	rs12113878(C;G)	None	31.0%
1747	rs13192841(A;G)	None	31.0%
1748	rs1341162(A;G)	None	31.0%
1749	rs1443512(A;C)	None	31.0%
1750	rs1796993(C;T)	None	31.0%
1751	rs1801132(C;G)	None	31.0%
1752	rs2145418(G;T)	None	31.0%	5.0x increased thyroid cancer risk
1753	rs2151145(C;T)	None	31.0%
1754	rs2229116(A;G)	None	31.0%
1755	rs2238472(A;G)	None	31.0%
1756	rs2340690(C;T)	None	31.0%
1757	rs2881766(G;T)	None	31.0%	increased risk for pregnancy-induced hypertension
1758	rs290487(C;T)	None	31.0%
1759	rs3129888(A;G)	None	31.0%
1760	rs3863747(C;T)	None	31.0%
1761	rs3949478(C;T)	None	31.0%
1762	rs4132509(A;C)	None	31.0%
1763	rs4329913(A;G)	None	31.0%
1764	rs460106(C;T)	None	31.0%
1765	rs4607103(C;T)	None	31.0%
1766	rs4754(C;T)	None	31.0%
1767	rs4917639(A;C)	None	31.0%
1768	rs5030878(C;T)	None	31.0%
1769	rs6489630(C;T)	None	31.0%
1770	rs6784434(A;G)	None	31.0%
1771	rs7539409(A;G)	None	31.0%
1772	rs8180115(C;T)	None	31.0%
1773	rs891835(G;T)	None	31.0%
1774	rs933688(C;T)	None	31.0%
1775	rs2003168(C;C)	None	31.1%
1776	rs3741208(C;T)	None	31.1%
1777	rs10510628(G;G)	None	31.2%
1778	rs1160542(A;A)	None	31.2%
1779	rs11970254(G;G)	None	31.2%
1780	rs1799998(T;T)	None	31.2%
1781	rs2115172(A;A)	None	31.2%
1782	rs237899(G;G)	None	31.2%
1783	rs3780412(A;A)	None	31.2%
1784	rs415407(T;T)	None	31.2%
1785	rs644148(G;G)	None	31.2%
1786	rs7173947(T;T)	None	31.2%
1787	rs728293(G;G)	None	31.2%
1788	rs9653442(T;T)	None	31.2%
1789	rs1052763(C;T)	None	31.2%
1790	rs13207033(A;G)	None	31.2%	None
1791	rs1528753(A;C)	None	31.2%
1792	rs1556314(G;T)	None	31.2%
1793	rs180730(C;T)	None	31.2%
1794	rs347519(C;T)	None	31.2%
1795	rs9399137(C;T)	None	31.2%
1796	rs10972341(G;G)	None	31.5%
1797	rs9674544(A;A)	None	31.5%
1798	rs7582694(C;G)	None	31.5%	1.71x increased SLE risk
1799	rs3218253(C;T)	None	31.7%
1800	rs1035938(C;T)	None	31.8%
1801	rs522616(A;G)	None	31.8%
1802	rs1046974(G;G)	None	31.9%
1803	rs10753575(T;T)	None	31.9%
1804	rs11190140(C;C)	None	31.9%
1805	rs13174252(A;A)	None	31.9%
1806	rs1370128(C;C)	None	31.9%
1807	rs1547251(T;T)	None	31.9%
1808	rs1556547(A;A)	None	31.9%
1809	rs1624395(G;G)	None	31.9%
1810	rs1846681(A;A)	None	31.9%
1811	rs2066713(C;C)	None	31.9%
1812	rs2078267(A;A)	None	31.9%
1813	rs2363956(G;G)	None	31.9%
1814	rs3057(A;A)	None	31.9%
1815	rs3094212(C;C)	None	31.9%
1816	rs3106796(A;A)	None	31.9%
1817	rs35683(C;C)	None	31.9%
1818	rs3734110(A;A)	None	31.9%
1819	rs3757385(C;C)	None	31.9%
1820	rs525455(A;A)	None	31.9%
1821	rs6880956(A;A)	None	31.9%
1822	rs732314(G;G)	None	31.9%
1823	rs744318(C;C)	None	31.9%
1824	rs749292(G;G)	None	31.9%
1825	rs752658(T;T)	None	31.9%
1826	rs889904(G;G)	None	31.9%
1827	rs10510102(A;G)	None	31.9%
1828	rs10793294(A;C)	None	31.9%
1829	rs12518099(A;G)	None	31.9%
1830	rs1265879(A;G)	None	31.9%
1831	rs1319501(C;T)	None	31.9%
1832	rs1407131(C;T)	None	31.9%
1833	rs1467558(A;G)	None	31.9%
1834	rs1487275(G;T)	None	31.9%
1835	rs1518111(A;G)	None	31.9%
1836	rs17411031(C;G)	None	31.9%
1837	rs17489268(A;T)	None	31.9%
1838	rs175646(C;T)	None	31.9%
1839	rs1800566(C;T)	None	31.9%
1840	rs1800872(A;C)	None	31.9%
1841	rs1930293(A;G)	None	31.9%
1842	rs2083637(C;T)	None	31.9%
1843	rs2205960(G;T)	None	31.9%
1844	rs2395182(G;T)	None	31.9%
1845	rs2499846(C;T)	None	31.9%
1846	rs2832387(A;G)	None	31.9%
1847	rs3734693(C;T)	None	31.9%
1848	rs3743200(C;T)	None	31.9%
1849	rs3763313(A;C)	None	31.9%
1850	rs3775261(A;C)	None	31.9%
1851	rs4833095(C;T)	None	31.9%
1852	rs4925189(A;G)	None	31.9%
1853	rs6647(C;T)	None	31.9%
1854	rs7078160(A;G)	None	31.9%
1855	rs7240405(A;G)	None	31.9%
1856	rs7313149(C;T)	None	31.9%
1857	rs7775698(C;T)	None	31.9%
1858	rs8003379(A;C)	None	31.9%
1859	rs9270986(A;C)	None	31.9%
1860	rs11568818(A;A)	None	32.1%
1861	rs2285714(C;C)	None	32.1%
1862	rs4409764(G;G)	None	32.1%
1863	rs6885224(T;T)	None	32.1%
1864	rs704010(G;G)	None	32.1%
1865	rs1048201(C;T)	None	32.1%
1866	rs11669977(A;G)	None	32.1%
1867	rs11989782(A;C)	None	32.1%
1868	rs12130333(C;T)	None	32.1%
1869	rs13263959(C;T)	None	32.1%
1870	rs1800871(C;T)	None	32.1%	0.5x decreased risk for endometriosis
1871	rs2108622(C;T)	None	32.1%	None
1872	rs4686799(C;T)	None	32.1%
1873	rs6859219(A;C)	None	32.1%
1874	rs1155974(T;T)	None	32.3%
1875	rs13281615(A;A)	None	32.3%
1876	rs1918974(T;T)	None	32.3%
1877	rs4606490(T;T)	None	32.3%
1878	rs6472866(C;C)	None	32.3%
1879	rs89107(A;A)	None	32.3%
1880	rs10493340(A;G)	None	32.3%
1881	rs10499194(C;T)	None	32.3%
1882	rs1248634(C;T)	None	32.3%
1883	rs2376803(A;G)	None	32.3%
1884	rs3766951(A;G)	None	32.3%
1885	rs436857(A;G)	None	32.3%
1886	rs4963(C;G)	None	32.3%
1887	rs515135(A;G)	None	32.3%
1888	rs6473797(C;T)	None	32.3%
1889	rs7557067(A;G)	None	32.3%
1890	rs11889862(A;G)	None	32.4%
1891	rs7716600(A;C)	None	32.4%
1892	rs10046(T;T)	None	32.7%
1893	rs1062708(T;T)	None	32.7%
1894	rs11203367(C;C)	None	32.7%
1895	rs11712165(T;T)	None	32.7%
1896	rs12800734(A;A)	None	32.7%
1897	rs12914385(C;C)	None	32.7%
1898	rs1441815(G;G)	None	32.7%
1899	rs2146098(A;A)	None	32.7%
1900	rs215614(A;A)	None	32.7%
1901	rs27048(C;C)	None	32.7%	2x risk of severe alcohol withdrawal
1902	rs3123078(T;T)	None	32.7%
1903	rs3747238(T;T)	None	32.7%
1904	rs3793243(C;C)	None	32.7%
1905	rs3794987(C;C)	None	32.7%
1906	rs504963(T;T)	None	32.7%
1907	rs5215(T;T)	None	32.7%
1908	rs583911(A;A)	None	32.7%
1909	rs6584283(C;C)	None	32.7%
1910	rs7142881(A;A)	None	32.7%
1911	rs756529(G;G)	None	32.7%
1912	rs7598440(T;T)	None	32.7%
1913	rs7830(C;C)	None	32.7%
1914	rs7920517(A;A)	None	32.7%
1915	rs864537(T;T)	None	32.7%
1916	rs10210358(A;G)	None	32.7%
1917	rs10503929(C;T)	None	32.7%
1918	rs1057091(C;T)	None	32.7%
1919	rs11602954(A;G)	None	32.7%
1920	rs11603020(C;T)	None	32.7%
1921	rs12946454(A;T)	None	32.7%
1922	rs1398024(A;C)	None	32.7%
1923	rs1452928(C;G)	None	32.7%
1924	rs17354547(A;C)	None	32.7%
1925	rs1801275(A;G)	None	32.7%
1926	rs1819741(C;T)	None	32.7%
1927	rs1881457(A;C)	None	32.7%
1928	rs1994090(G;T)	None	32.7%
1929	rs2066219(C;T)	None	32.7%
1930	rs2104286(A;G)	None	32.7%	1.4x risk for RA; 1.3x for T1D; also MS?
1931	rs2156552(A;T)	None	32.7%
1932	rs2276307(A;G)	None	32.7%
1933	rs2601828(A;G)	None	32.7%
1934	rs267734(A;G)	None	32.7%
1935	rs2786098(A;C)	None	32.7%
1936	rs285757(C;T)	None	32.7%
1937	rs2953145(C;G)	None	32.7%	1.8x risk
1938	rs3020443(A;C)	None	32.7%
1939	rs3024490(G;T)	None	32.7%
1940	rs3764147(A;G)	None	32.7%
1941	rs3775296(G;T)	None	32.7%
1942	rs389719(C;T)	None	32.7%
1943	rs4466137(G;T)	None	32.7%
1944	rs506585(A;G)	None	32.7%
1945	rs647316(A;G)	None	32.7%
1946	rs699946(A;G)	None	32.7%
1947	rs7279441(A;G)	None	32.7%
1948	rs8020441(G;T)	None	32.7%
1949	rs980989(G;T)	None	32.7%
1950	rs11031434(G;G)	None	32.8%
1951	rs1260333(C;C)	None	32.8%
1952	rs2523393(C;C)	None	32.8%
1953	rs35682(A;A)	None	32.8%
1954	rs4147141(A;A)	None	32.8%
1955	rs17036314(C;G)	None	32.8%	risk of progressing from IGT to T2D; reduced by exercise
1956	rs2279591(A;G)	None	32.8%
1957	rs2387326(A;G)	None	32.8%
1958	rs4411417(C;T)	None	32.8%
1959	rs752688(C;T)	None	32.8%
1960	rs9373124(C;T)	None	32.8%
1961	rs10865355(G;G)	None	33.0%
1962	rs1260326(C;C)	None	33.0%
1963	rs2438146(C;C)	None	33.0%
1964	rs3924999(C;C)	None	33.0%
1965	rs10501570(C;T)	None	33.0%
1966	rs17520378(C;G)	None	33.0%
1967	rs4321143(A;G)	None	33.0%
1968	rs4775065(A;G)	None	33.0%
1969	rs7296239(C;T)	None	33.0%
1970	rs867559(A;G)	None	33.0%
1971	rs1011731(T;T)	None	33.3%
1972	rs9306160(C;C)	None	33.3%	normal
1973	rs11159647(A;G)	None	33.3%
1974	rs1322784(C;T)	None	33.3%
1975	rs17646946(A;G)	None	33.3%
1976	rs2509897(C;G)	None	33.3%
1977	rs393548(A;T)	None	33.3%
1978	rs501764(G;T)	None	33.3%
1979	rs10204137(A;A)	None	33.6%
1980	rs11203366(A;A)	None	33.6%
1981	rs11597086(A;A)	None	33.6%
1982	rs11636232(C;C)	None	33.6%
1983	rs1167796(G;G)	None	33.6%
1984	rs11897119(T;T)	None	33.6%
1985	rs12478601(T;T)	None	33.6%
1986	rs1414896(A;A)	None	33.6%
1987	rs1940033(T;T)	None	33.6%
1988	rs2228622(G;G)	None	33.6%
1989	rs2274894(G;G)	None	33.6%
1990	rs2704188(T;T)	None	33.6%
1991	rs2725362(G;G)	None	33.6%
1992	rs2784773(C;C)	None	33.6%
1993	rs2860580(C;C)	None	33.6%
1994	rs3115573(T;T)	None	33.6%
1995	rs3771166(C;C)	None	33.6%
1996	rs3798577(T;T)	None	33.6%
1997	rs4988957(T;T)	None	33.6%
1998	rs627928(G;G)	None	33.6%
1999	rs6494223(C;C)	None	33.6%	normal
2000	rs6763931(G;G)	None	33.6%
2001	rs698078(T;T)	None	33.6%
2002	rs710446(A;A)	None	33.6%
2003	rs767199(A;A)	None	33.6%
2004	rs7784776(A;A)	None	33.6%
2005	rs7892812(A;A)	None	33.6%
2006	rs7933505(G;G)	None	33.6%
2007	rs7963521(T;T)	None	33.6%
2008	rs892086(T;T)	None	33.6%	1.5x increased Alzheimer risk in non-ApoE4 carriers
2009	rs10035961(A;C)	None	33.6%
2010	rs10168266(C;T)	None	33.6%
2011	rs11221332(C;T)	None	33.6%
2012	rs11622475(C;T)	None	33.6%	1.1x risk
2013	rs1176713(C;T)	None	33.6%
2014	rs12531488(C;T)	None	33.6%
2015	rs13015714(G;T)	None	33.6%
2016	rs135551(C;T)	None	33.6%
2017	rs1371924(A;G)	None	33.6%
2018	rs1402812(C;G)	None	33.6%
2019	rs1412337(C;T)	None	33.6%
2020	rs1491923(C;T)	None	33.6%
2021	rs17689437(C;T)	None	33.6%
2022	rs17818902(G;T)	None	33.6%
2023	rs1800802(C;T)	None	33.6%
2024	rs1885088(A;G)	None	33.6%
2025	rs2040704(A;G)	None	33.6%
2026	rs2240032(C;T)	None	33.6%
2027	rs2244012(C;T)	None	33.6%
2028	rs2421853(A;G)	None	33.6%
2029	rs2842951(C;T)	None	33.6%
2030	rs458685(C;T)	None	33.6%
2031	rs4599440(C;T)	None	33.6%
2032	rs4715(A;C)	None	33.6%
2033	rs4886707(C;T)	None	33.6%
2034	rs4949184(C;T)	None	33.6%
2035	rs4956396(C;T)	None	33.6%
2036	rs4961(G;T)	None	33.6%	1.8x increased risk for high blood pressure
2037	rs6843082(A;G)	None	33.6%
2038	rs7025486(A;G)	None	33.6%
2039	rs7297245(C;T)	None	33.6%
2040	rs7969151(A;G)	None	33.6%
2041	rs917997(A;G)	None	33.6%
2042	rs1048108(C;C)	None	33.8%
2043	rs1585215(A;A)	None	33.8%	normal
2044	rs1824938(T;T)	None	33.8%
2045	rs2650427(C;C)	None	33.8%
2046	rs285(T;T)	None	33.8%
2047	rs4608580(T;T)	None	33.8%
2048	rs4822489(G;G)	None	33.8%
2049	rs522958(T;T)	None	33.8%
2050	rs7595103(A;A)	None	33.8%
2051	rs931794(A;A)	None	33.8%
2052	rs10116253(C;T)	None	33.8%
2053	rs1126809(A;G)	None	33.8%	slight increase in skin cancer risk
2054	rs16840639(C;T)	None	33.8%
2055	rs16999684(A;C)	None	33.8%
2056	rs2114358(C;T)	None	33.8%
2057	rs2190004(C;T)	None	33.8%
2058	rs222029(A;G)	None	33.8%
2059	rs363064(A;G)	None	33.8%
2060	rs4076128(A;G)	None	33.8%	normal
2061	rs4926(A;G)	None	33.8%
2062	rs4979459(G;T)	None	33.8%
2063	rs5745718(A;C)	None	33.8%
2064	rs6539870(A;G)	None	33.8%
2065	rs7968722(C;T)	None	33.8%
2066	rs9276977(A;G)	None	33.8%
2067	rs10091038(C;C)	None	33.9%
2068	rs1836127(G;G)	None	33.9%
2069	rs229541(C;C)	None	33.9%
2070	rs2395185(G;G)	None	33.9%
2071	rs410644(T;T)	None	33.9%
2072	rs4135247(A;A)	None	33.9%
2073	rs6807670(A;A)	None	33.9%
2074	rs11196218(A;G)	None	33.9%
2075	rs12039904(C;T)	None	33.9%
2076	rs12367822(G;T)	None	33.9%
2077	rs1805124(A;G)	None	33.9%
2078	rs4296809(A;C)	None	33.9%
2079	rs8007267(C;T)	None	33.9%
2080	rs9529500(C;T)	None	33.9%
2081	rs320(G;T)	None	34.0%
2082	rs3788013(C;C)	None	34.2%
2083	rs11626056(C;T)	None	34.2%
2084	rs1933695(A;G)	None	34.2%
2085	rs251124(C;T)	None	34.2%
2086	rs2970869(A;G)	None	34.2%
2087	rs954295(A;C)	None	34.2%
2088	rs11663391(C;C)	None	34.3%
2089	rs11803731(A;T)	None	34.4%
2090	rs1025398(A;A)	None	34.5%
2091	rs10798269(G;G)	None	34.5%
2092	rs1209950(C;C)	None	34.5%
2093	rs12313946(C;C)	None	34.5%
2094	rs12333032(T;T)	None	34.5%
2095	rs13120078(G;G)	None	34.5%
2096	rs1405069(T;T)	None	34.5%
2097	rs1544410(G;G)	None	34.5%
2098	rs17483929(G;G)	None	34.5%
2099	rs1800532(C;C)	None	34.5%
2100	rs2145270(T;T)	None	34.5%
2101	rs2244305(C;C)	None	34.5%
2102	rs2281808(C;C)	None	34.5%
2103	rs229527(G;G)	None	34.5%
2104	rs3181098(G;G)	None	34.5%
2105	rs359457(T;T)	None	34.5%
2106	rs3746722(A;A)	None	34.5%
2107	rs470119(G;G)	None	34.5%
2108	rs4712652(A;A)	None	34.5%
2109	rs4728142(G;G)	None	34.5%
2110	rs4785763(C;C)	None	34.5%
2111	rs513349(A;A)	None	34.5%
2112	rs602662(A;A)	None	34.5%
2113	rs6123837(G;G)	None	34.5%
2114	rs6440003(G;G)	None	34.5%
2115	rs6496074(A;A)	None	34.5%
2116	rs6582630(A;A)	None	34.5%
2117	rs6812193(C;C)	None	34.5%
2118	rs6868223(A;A)	None	34.5%
2119	rs700518(G;G)	None	34.5%
2120	rs7177792(C;C)	None	34.5%
2121	rs731236(T;T)	None	34.5%
2122	rs8034191(T;T)	None	34.5%	normal
2123	rs944895(T;T)	None	34.5%
2124	rs9820070(A;A)	None	34.5%
2125	rs9976767(A;A)	None	34.5%
2126	rs1008642(C;T)	None	34.5%
2127	rs1034200(G;T)	None	34.5%
2128	rs10482633(A;C)	None	34.5%
2129	rs10505476(A;G)	None	34.5%
2130	rs10848911(A;G)	None	34.5%
2131	rs12569163(G;T)	None	34.5%
2132	rs12913832(A;G)	None	34.5%	brown eye color
2133	rs13283456(C;T)	None	34.5%
2134	rs1399180(C;T)	None	34.5%
2135	rs1443548(C;T)	None	34.5%
2136	rs1554973(C;T)	None	34.5%	increased risk for chorionic plate inflammation
2137	rs17584499(C;T)	None	34.5%
2138	rs1801157(A;G)	None	34.5%
2139	rs1831521(C;T)	None	34.5%
2140	rs1847134(A;C)	None	34.5%
2141	rs1928042(A;C)	None	34.5%
2142	rs2072115(C;T)	None	34.5%
2143	rs2075671(C;T)	None	34.5%
2144	rs2239179(A;G)	None	34.5%
2145	rs2242330(C;T)	None	34.5%
2146	rs2267439(C;T)	None	34.5%
2147	rs2275215(C;T)	None	34.5%
2148	rs2304069(G;T)	None	34.5%
2149	rs2910164(C;G)	None	34.5%	higher/earlier cancer likelihood??
2150	rs2961920(A;C)	None	34.5%
2151	rs3815148(A;C)	None	34.5%
2152	rs3827143(A;G)	None	34.5%
2153	rs3917187(A;G)	None	34.5%
2154	rs4923705(A;G)	None	34.5%
2155	rs6051520(G;T)	None	34.5%
2156	rs6198(A;G)	None	34.5%
2157	rs6566561(A;G)	None	34.5%
2158	rs6569648(C;T)	None	34.5%
2159	rs6741029(G;T)	None	34.5%
2160	rs749909(C;T)	None	34.5%
2161	rs7602358(G;T)	None	34.5%
2162	rs7786877(A;G)	None	34.5%
2163	rs7866070(A;G)	None	34.5%
2164	rs874426(G;T)	None	34.5%
2165	rs9467160(A;G)	None	34.5%
2166	rs17318596(G;G)	None	34.8%
2167	rs2070006(G;G)	None	34.8%
2168	rs2522833(A;A)	None	34.8%
2169	rs4986764(C;C)	None	34.8%
2170	rs724016(A;A)	None	34.8%
2171	rs7930940(G;G)	None	34.8%
2172	rs13157656(A;C)	None	34.8%
2173	rs3118523(A;G)	None	34.8%
2174	rs5985(G;T)	None	34.8%
2175	rs1317286(A;A)	None	34.9%
2176	rs390312(C;C)	None	34.9%
2177	rs12714207(C;T)	None	34.9%
2178	rs3108919(C;T)	None	34.9%
2179	rs7894737(A;A)	None	35.0%
2180	rs757110(T;T)	None	35.1%
2181	rs11254363(A;G)	None	35.1%
2182	rs1454292(T;T)	None	35.2%
2183	rs2274432(C;C)	None	35.2%
2184	rs4908449(C;C)	None	35.2%
2185	rs1013368(T;T)	None	35.4%
2186	rs1024323(G;G)	None	35.4%
2187	rs10770141(G;G)	None	35.4%
2188	rs11887120(C;C)	None	35.4%
2189	rs1324015(G;G)	None	35.4%
2190	rs1474747(T;T)	None	35.4%
2191	rs1635517(T;T)	None	35.4%
2192	rs1644305(C;C)	None	35.4%
2193	rs17483721(T;T)	None	35.4%
2194	rs17487223(C;C)	None	35.4%
2195	rs17645523(T;T)	None	35.4%
2196	rs2036417(G;G)	None	35.4%
2197	rs2073233(T;T)	None	35.4%
2198	rs216345(C;C)	None	35.4%
2199	rs2228001(A;A)	None	35.4%	statistically significant, but slight, increase in lung cancer risk
2200	rs2239393(A;A)	None	35.4%
2201	rs2254958(C;C)	None	35.4%	1.61x increased risk for Alzheimer's
2202	rs2294015(A;A)	None	35.4%
2203	rs2424913(C;C)	None	35.4%
2204	rs2433320(G;G)	None	35.4%
2205	rs2433322(T;T)	None	35.4%
2206	rs2827196(T;T)	None	35.4%
2207	rs2844724(A;A)	None	35.4%
2208	rs3774426(C;C)	None	35.4%	better response to certain calcium channel blockers
2209	rs4298437(C;C)	None	35.4%
2210	rs530501(A;A)	None	35.4%
2211	rs585344(C;C)	None	35.4%
2212	rs6165(A;A)	None	35.4%
2213	rs6166(A;A)	None	35.4%	normal risk
2214	rs7190823(T;T)	None	35.4%
2215	rs855791(C;C)	None	35.4%	normal
2216	rs9268858(T;T)	None	35.4%
2217	rs9324677(C;C)	None	35.4%
2218	rs9354308(A;A)	None	35.4%
2219	rs9630182(C;C)	None	35.4%
2220	rs10036748(C;T)	None	35.4%
2221	rs10514585(C;T)	None	35.4%
2222	rs10521157(A;G)	None	35.4%
2223	rs10911902(C;T)	None	35.4%
2224	rs10941679(A;G)	None	35.4%
2225	rs1110866(A;C)	None	35.4%
2226	rs11110912(C;G)	None	35.4%	1.3x risk
2227	rs11187033(A;T)	None	35.4%
2228	rs12122100(C;T)	None	35.4%
2229	rs12718597(A;C)	None	35.4%
2230	rs1386482(A;C)	None	35.4%
2231	rs1386486(C;T)	None	35.4%
2232	rs1402467(C;G)	None	35.4%
2233	rs1415985(C;T)	None	35.4%
2234	rs16955329(G;T)	None	35.4%
2235	rs1733724(C;T)	None	35.4%
2236	rs17651507(A;T)	None	35.4%
2237	rs1800588(C;T)	None	35.4%
2238	rs1970546(A;G)	None	35.4%
2239	rs2227564(C;T)	None	35.4%
2240	rs2268624(C;G)	None	35.4%
2241	rs2290113(C;T)	None	35.4%
2242	rs236114(A;G)	None	35.4%
2243	rs241447(A;G)	None	35.4%
2244	rs241453(C;T)	None	35.4%
2245	rs2746071(A;G)	None	35.4%
2246	rs294223(A;G)	None	35.4%
2247	rs3020314(C;T)	None	35.4%	0.64x reduced lymphoma risk
2248	rs3093457(G;T)	None	35.4%
2249	rs3127599(A;G)	None	35.4%
2250	rs3180018(A;G)	None	35.4%
2251	rs326(A;G)	None	35.4%	lower HDL cholesterol
2252	rs3735273(A;G)	None	35.4%
2253	rs3757713(G;T)	None	35.4%
2254	rs3786954(A;G)	None	35.4%
2255	rs3790844(C;T)	None	35.4%
2256	rs3823720(A;G)	None	35.4%
2257	rs3864283(C;T)	None	35.4%
2258	rs4290270(A;T)	None	35.4%
2259	rs4520070(G;T)	None	35.4%
2260	rs479341(A;G)	None	35.4%
2261	rs4895441(A;G)	None	35.4%
2262	rs4897475(A;G)	None	35.4%
2263	rs4900384(A;G)	None	35.4%
2264	rs549908(G;T)	None	35.4%
2265	rs579459(C;T)	None	35.4%
2266	rs651007(A;G)	None	35.4%
2267	rs757092(A;G)	None	35.4%
2268	rs7959052(C;T)	None	35.4%
2269	rs8085804(C;T)	None	35.4%
2270	rs849141(A;G)	None	35.4%
2271	rs908821(C;T)	None	35.4%
2272	rs9321013(A;G)	None	35.4%
2273	rs950169(A;G)	None	35.4%
2274	rs9585056(C;T)	None	35.4%
2275	rs976748(C;T)	None	35.4%
2276	rs1451371(T;T)	None	35.5%
2277	rs2298383(T;T)	None	35.5%
2278	rs11222291(C;T)	None	35.5%
2279	rs2070895(A;G)	None	35.5%
2280	rs2292832(C;T)	None	35.5%
2281	rs2073831(C;C)	None	35.7%
2282	rs2383393(C;C)	None	35.7%
2283	rs10799655(C;T)	None	35.7%
2284	rs2073438(A;G)	None	35.7%
2285	rs233115(C;C)	None	35.8%
2286	rs1884613(C;G)	None	35.8%
2287	rs2288904(C;T)	None	35.8%
2288	rs2287921(C;C)	None	35.9%
2289	rs759158(T;T)	None	35.9%
2290	rs811(A;A)	None	35.9%
2291	rs4729260(C;G)	None	35.9%
2292	rs755109(T;T)	None	36.0%
2293	rs8002779(A;A)	None	36.0%
2294	rs886774(A;A)	None	36.0%
2295	rs241448(C;T)	None	36.0%	1.51x increased risk for Alzheimer's
2296	rs495828(G;T)	None	36.0%
2297	rs6590495(C;T)	None	36.2%
2298	rs806606(C;T)	None	36.2%
2299	rs10181042(C;C)	None	36.3%
2300	rs11535853(C;C)	None	36.3%
2301	rs11858113(T;T)	None	36.3%
2302	rs11898505(G;G)	None	36.3%
2303	rs12573606(A;A)	None	36.3%
2304	rs1397048(G;G)	None	36.3%
2305	rs156697(T;T)	None	36.3%
2306	rs1574192(C;C)	None	36.3%
2307	rs1648707(A;A)	None	36.3%
2308	rs2070106(G;G)	None	36.3%
2309	rs2422493(C;C)	None	36.3%
2310	rs2435207(G;G)	None	36.3%
2311	rs2582869(G;G)	None	36.3%
2312	rs2624265(T;T)	None	36.3%
2313	rs272893(G;G)	None	36.3%
2314	rs2899470(G;G)	None	36.3%
2315	rs2989727(T;T)	None	36.3%
2316	rs361147(A;A)	None	36.3%
2317	rs39395(A;A)	None	36.3%
2318	rs4453795(A;A)	None	36.3%
2319	rs4713518(A;A)	None	36.3%
2320	rs477515(C;C)	None	36.3%
2321	rs614230(T;T)	None	36.3%
2322	rs6752877(T;T)	None	36.3%
2323	rs7602460(G;G)	None	36.3%
2324	rs780093(G;G)	None	36.3%
2325	rs838705(A;A)	None	36.3%
2326	rs10518765(A;C)	None	36.3%
2327	rs10789082(C;T)	None	36.3%
2328	rs10865710(C;G)	None	36.3%
2329	rs11724368(A;T)	None	36.3%
2330	rs12536657(A;G)	None	36.3%
2331	rs12593008(A;C)	None	36.3%
2332	rs12628(C;T)	None	36.3%
2333	rs13073869(A;G)	None	36.3%
2334	rs1484948(C;T)	None	36.3%
2335	rs15763(C;T)	None	36.3%
2336	rs205763(A;G)	None	36.3%
2337	rs2107301(C;T)	None	36.3%	?
2338	rs2149632(C;T)	None	36.3%
2339	rs2230808(A;G)	None	36.3%
2340	rs2359991(C;T)	None	36.3%
2341	rs251177(C;T)	None	36.3%	somewhat higher risk for prostate cancer
2342	rs2638525(A;G)	None	36.3%
2343	rs2648875(A;G)	None	36.3%
2344	rs2814828(C;T)	None	36.3%
2345	rs3136817(C;T)	None	36.3%
2346	rs3747517(A;G)	None	36.3%
2347	rs3758391(C;T)	None	36.3%	less mental decline with age
2348	rs3779456(C;T)	None	36.3%
2349	rs3811047(A;G)	None	36.3%
2350	rs419558(C;T)	None	36.3%
2351	rs4804611(A;G)	None	36.3%
2352	rs4888024(A;G)	None	36.3%
2353	rs4978584(C;T)	None	36.3%
2354	rs4988235(C;T)	None	36.3%	can digest milk
2355	rs6596075(C;G)	None	36.3%	1.5x risk
2356	rs6937133(A;G)	None	36.3%
2357	rs7032940(A;G)	None	36.3%
2358	rs727957(G;T)	None	36.3%
2359	rs7944584(A;T)	None	36.3%
2360	rs910079(A;G)	None	36.3%
2361	rs9277535(A;G)	None	36.3%
2362	rs9376092(A;C)	None	36.3%
2363	rs950063(C;T)	None	36.3%
2364	rs1743(A;T)	None	36.4%
2365	rs4679904(C;T)	None	36.4%
2366	rs495366(A;G)	None	36.4%
2367	rs7121446(A;G)	None	36.4%
2368	rs12287931(A;G)	None	36.5%
2369	rs3793917(C;G)	None	36.5%
2370	rs3093030(C;C)	None	36.6%
2371	rs3181348(C;C)	None	36.6%
2372	rs543650(C;C)	None	36.6%
2373	rs642698(G;G)	None	36.6%
2374	rs697739(G;G)	None	36.6%
2375	rs815198(C;C)	None	36.6%
2376	rs10421768(A;G)	None	36.6%
2377	rs2235749(A;G)	None	36.6%
2378	rs17609240(G;T)	None	36.8%
2379	rs10483727(C;C)	None	36.9%
2380	rs11243897(A;A)	None	36.9%
2381	rs1143643(G;G)	None	36.9%
2382	rs1200821(T;T)	None	36.9%
2383	rs2073163(C;C)	None	36.9%
2384	rs2227306(C;C)	None	36.9%
2385	rs2240340(G;G)	None	36.9%	average
2386	rs2573905(C;C)	None	36.9%
2387	rs3104793(T;T)	None	36.9%
2388	rs4026608(T;T)	None	36.9%
2389	rs4327572(C;C)	None	36.9%
2390	rs7318731(C;C)	None	36.9%
2391	rs11737074(A;G)	None	36.9%
2392	rs151290(A;C)	None	36.9%
2393	rs1582055(C;T)	None	36.9%
2394	rs17027230(C;T)	None	36.9%
2395	rs1801253(C;G)	None	36.9%	depends on [[rs1801252]]
2396	rs1933182(G;T)	None	36.9%
2397	rs2274158(G;T)	None	36.9%
2398	rs2301612(C;G)	None	36.9%
2399	rs3931914(C;G)	None	36.9%
2400	rs650108(A;G)	None	36.9%
2401	rs666088(A;G)	None	36.9%
2402	rs8050894(C;G)	None	36.9%
2403	rs910049(A;G)	None	36.9%
2404	rs6922269(A;G)	None	37.0%	1.2x risk
2405	rs7749390(A;A)	None	37.1%
2406	rs2292912(C;G)	None	37.1%
2407	rs3782905(C;G)	None	37.1%
2408	rs6504950(A;G)	None	37.1%
2409	rs1014064(A;A)	None	37.2%
2410	rs10519203(A;A)	None	37.2%
2411	rs12808199(A;A)	None	37.2%
2412	rs1411766(C;C)	None	37.2%
2413	rs1801262(G;G)	None	37.2%
2414	rs181736(G;G)	None	37.2%
2415	rs182052(G;G)	None	37.2%
2416	rs1840440(C;C)	None	37.2%
2417	rs2036527(C;C)	None	37.2%
2418	rs2384550(G;G)	None	37.2%
2419	rs2530223(C;C)	None	37.2%
2420	rs2773080(C;C)	None	37.2%
2421	rs3780901(T;T)	None	37.2%
2422	rs3806156(G;G)	None	37.2%
2423	rs3807375(G;G)	None	37.2%
2424	rs4085613(C;C)	None	37.2%
2425	rs409045(T;T)	None	37.2%
2426	rs4112788(C;C)	None	37.2%
2427	rs4522865(A;A)	None	37.2%
2428	rs4721(A;A)	None	37.2%
2429	rs496300(A;A)	None	37.2%
2430	rs5030062(A;A)	None	37.2%
2431	rs606149(G;G)	None	37.2%
2432	rs645088(C;C)	None	37.2%
2433	rs6606697(G;G)	None	37.2%
2434	rs674210(A;A)	None	37.2%
2435	rs7125774(T;T)	None	37.2%
2436	rs739837(T;T)	None	37.2%
2437	rs741846(G;G)	None	37.2%
2438	rs7704909(T;T)	None	37.2%
2439	rs7713917(A;A)	None	37.2%
2440	rs7975232(A;A)	None	37.2%
2441	rs854547(A;A)	None	37.2%
2442	rs854555(C;C)	None	37.2%
2443	rs979752(C;C)	None	37.2%
2444	rs10229603(C;T)	None	37.2%
2445	rs10272030(A;G)	None	37.2%
2446	rs1040994(A;C)	None	37.2%
2447	rs10501087(C;T)	None	37.2%
2448	rs11030104(A;G)	None	37.2%
2449	rs1324214(A;G)	None	37.2%
2450	rs1386483(A;G)	None	37.2%
2451	rs1417507(A;G)	None	37.2%
2452	rs1701704(A;C)	None	37.2%
2453	rs17146964(A;G)	None	37.2%
2454	rs17478107(C;T)	None	37.2%
2455	rs1805123(A;C)	None	37.2%
2456	rs1927911(C;T)	None	37.2%	0.88x lower risk of nonfatal myocardial infarction
2457	rs199533(C;T)	None	37.2%
2458	rs2070863(C;T)	None	37.2%
2459	rs2134655(A;G)	None	37.2%
2460	rs2227956(C;T)	None	37.2%
2461	rs2234689(C;G)	None	37.2%
2462	rs227060(C;T)	None	37.2%
2463	rs2304204(A;G)	None	37.2%
2464	rs245111(C;T)	None	37.2%
2465	rs2502815(C;T)	None	37.2%
2466	rs287235(C;G)	None	37.2%
2467	rs362272(C;T)	None	37.2%
2468	rs3745367(A;G)	None	37.2%
2469	rs3793427(C;G)	None	37.2%
2470	rs4364254(C;T)	None	37.2%
2471	rs4369779(C;T)	None	37.2%
2472	rs4715630(C;T)	None	37.2%
2473	rs4800148(A;G)	None	37.2%
2474	rs4923461(A;G)	None	37.2%
2475	rs4935969(C;T)	None	37.2%
2476	rs6013509(A;G)	None	37.2%
2477	rs6458307(C;T)	None	37.2%	0.8x risk
2478	rs6686643(C;T)	None	37.2%
2479	rs6691170(G;T)	None	37.2%
2480	rs6726035(C;T)	None	37.2%
2481	rs6985504(A;G)	None	37.2%
2482	rs7085104(A;G)	None	37.2%
2483	rs7222197(A;G)	None	37.2%
2484	rs7590268(G;T)	None	37.2%
2485	rs7731657(C;T)	None	37.2%
2486	rs7804356(C;T)	None	37.2%
2487	rs7946(C;T)	None	37.2%
2488	rs9472138(C;T)	None	37.2%
2489	rs9623117(C;T)	None	37.2%	1.1x increased risk for prostate cancer
2490	rs9943849(C;T)	None	37.2%
2491	rs13143308(G;T)	None	37.3%
2492	rs10955255(G;G)	None	37.5%
2493	rs2229741(G;G)	None	37.5%
2494	rs2278034(G;G)	None	37.5%
2495	rs2393967(A;A)	None	37.5%
2496	rs261360(G;G)	None	37.5%
2497	rs2930291(C;C)	None	37.5%	1.5x risk
2498	rs3761422(C;C)	None	37.5%
2499	rs8176720(A;A)	None	37.5%
2500	rs1049353(A;G)	None	37.5%	more resistant to treatment for depression

The file is too large to be shown. View Raw